0000766704false2021Q1December 31P1Ywell:LeaseRightOfUseAssetwell:LeaseRightOfUseAssetwell:LeaseRightOfUseAssetwell:LeaseRightOfUseAssetwell:LeaseLiabilitywell:LeaseLiabilitywell:LeaseLiabilitywell:LeaseLiabilitywell:ReceivablesAndOtherAssetswell:ReceivablesAndOtherAssetsus-gaap:AccountingStandardsUpdate201613MemberP3Y00007667042021-01-012021-03-310000766704us-gaap:CommonStockMember2021-01-012021-03-310000766704well:NotesDue20284.800Member2021-01-012021-03-310000766704well:NotesDue20344.500Member2021-01-012021-03-31xbrli:shares00007667042021-04-23iso4217:USD00007667042021-03-3100007667042020-12-310000766704us-gaap:ManagementServiceMember2021-01-012021-03-310000766704us-gaap:ManagementServiceMember2020-01-012020-03-3100007667042020-01-012020-03-310000766704well:InterestRevenueMember2021-01-012021-03-310000766704well:InterestRevenueMember2020-01-012020-03-310000766704us-gaap:ProductAndServiceOtherMember2021-01-012021-03-310000766704us-gaap:ProductAndServiceOtherMember2020-01-012020-03-31iso4217:USDxbrli:shares0000766704us-gaap:CommonStockMember2020-12-310000766704us-gaap:AdditionalPaidInCapitalMember2020-12-310000766704us-gaap:TreasuryStockMember2020-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2020-12-310000766704well:AccumulatedDistributionsMember2020-12-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000766704us-gaap:NoncontrollingInterestMember2020-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2021-01-012021-03-310000766704us-gaap:NoncontrollingInterestMember2021-01-012021-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310000766704us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310000766704us-gaap:CommonStockMember2021-01-012021-03-310000766704us-gaap:TreasuryStockMember2021-01-012021-03-310000766704well:AccumulatedDistributionsMember2021-01-012021-03-310000766704us-gaap:CommonStockMember2021-03-310000766704us-gaap:AdditionalPaidInCapitalMember2021-03-310000766704us-gaap:TreasuryStockMember2021-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2021-03-310000766704well:AccumulatedDistributionsMember2021-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310000766704us-gaap:NoncontrollingInterestMember2021-03-310000766704us-gaap:CommonStockMember2019-12-310000766704us-gaap:AdditionalPaidInCapitalMember2019-12-310000766704us-gaap:TreasuryStockMember2019-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2019-12-310000766704well:AccumulatedDistributionsMember2019-12-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310000766704us-gaap:NoncontrollingInterestMember2019-12-3100007667042019-12-310000766704srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:RetainedEarningsUnappropriatedMember2019-12-310000766704srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-12-310000766704srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:CommonStockMember2019-12-310000766704srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:AdditionalPaidInCapitalMember2019-12-310000766704srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:TreasuryStockMember2019-12-310000766704srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:RetainedEarningsUnappropriatedMember2019-12-310000766704srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberwell:AccumulatedDistributionsMember2019-12-310000766704srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310000766704srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMemberus-gaap:NoncontrollingInterestMember2019-12-310000766704srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2019-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2020-01-012020-03-310000766704us-gaap:NoncontrollingInterestMember2020-01-012020-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-03-310000766704us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-310000766704us-gaap:CommonStockMember2020-01-012020-03-310000766704us-gaap:TreasuryStockMember2020-01-012020-03-310000766704well:AccumulatedDistributionsMember2020-01-012020-03-310000766704us-gaap:CommonStockMember2020-03-310000766704us-gaap:AdditionalPaidInCapitalMember2020-03-310000766704us-gaap:TreasuryStockMember2020-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2020-03-310000766704well:AccumulatedDistributionsMember2020-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310000766704us-gaap:NoncontrollingInterestMember2020-03-3100007667042020-03-31xbrli:pure0000766704well:SeniorHousingOperatingMemberwell:COVID19Member2021-03-310000766704well:SeniorHousingOperatingMemberwell:COVID19Member2020-12-310000766704well:SeniorHousingOperatingMemberwell:COVID19Member2020-02-290000766704well:SeniorHousingOperatingMemberwell:COVID19Member2021-01-300000766704well:SeniorHousingOperatingMemberwell:COVID19Member2021-02-280000766704well:COVID19Member2021-01-012021-03-310000766704well:COVID19Memberwell:OutpatientMedicalSegmentMember2021-01-012021-03-310000766704well:SeniorHousingOperatingMember2021-03-310000766704well:TripleNetMember2021-03-310000766704well:OutpatientMedicalMember2021-03-310000766704well:SeniorHousingOperatingMember2020-03-310000766704well:TripleNetMember2020-03-310000766704well:OutpatientMedicalMember2020-03-310000766704well:SeniorHousingOperatingMember2021-01-012021-03-310000766704well:TripleNetMember2021-01-012021-03-310000766704well:OutpatientMedicalMember2021-01-012021-03-310000766704well:SeniorHousingOperatingMember2020-01-012020-03-310000766704well:TripleNetMember2020-01-012020-03-310000766704well:OutpatientMedicalMember2020-01-012020-03-310000766704us-gaap:LeasesAcquiredInPlaceMember2021-03-310000766704us-gaap:LeasesAcquiredInPlaceMember2020-12-310000766704us-gaap:AboveMarketLeasesMember2021-03-310000766704us-gaap:AboveMarketLeasesMember2020-12-310000766704well:LeaseCommissionsMember2021-03-310000766704well:LeaseCommissionsMember2020-12-3100007667042020-01-012020-12-31well:property0000766704us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2021-03-310000766704us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2021-01-012021-03-310000766704us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2020-01-012020-03-310000766704srt:MinimumMember2021-01-012021-03-310000766704srt:MaximumMember2021-01-012021-03-310000766704us-gaap:CostOfSalesMember2021-01-012021-03-310000766704us-gaap:CostOfSalesMember2020-01-012020-03-310000766704us-gaap:GeneralAndAdministrativeExpenseMember2021-01-012021-03-310000766704us-gaap:GeneralAndAdministrativeExpenseMember2020-01-012020-03-310000766704us-gaap:OperatingSegmentsMember2021-03-310000766704us-gaap:OperatingSegmentsMember2020-12-310000766704us-gaap:CorporateNonSegmentMember2021-03-310000766704us-gaap:CorporateNonSegmentMember2020-12-310000766704well:OperatingSegmentsAndCorporateNonSegmentMember2021-03-310000766704well:OperatingSegmentsAndCorporateNonSegmentMember2020-12-310000766704us-gaap:MortgageReceivablesMember2021-03-310000766704us-gaap:MortgageReceivablesMember2020-12-310000766704well:OtherRealEstateLoansReceivablesMember2021-03-310000766704well:OtherRealEstateLoansReceivablesMember2020-12-310000766704us-gaap:RealEstateLoanMember2021-03-310000766704us-gaap:RealEstateLoanMember2020-12-31iso4217:GBP0000766704us-gaap:SubsequentEventMemberwell:SafanadMember2021-04-290000766704us-gaap:SubsequentEventMemberwell:SafanadMember2021-04-012021-04-290000766704us-gaap:SubsequentEventMemberwell:HCOneLimitedMember2021-04-290000766704well:DeterioratedLoansMember2021-03-31well:loan0000766704well:CollectiveLoanPool1Member2021-03-310000766704well:CollectiveLoanPool2Member2021-03-310000766704well:CollectiveLoanPool3Member2021-03-310000766704well:CollectiveLoanPool4Member2021-03-310000766704well:CollectiveLoanPool5Member2021-03-310000766704well:CollectiveLoanPool6Member2021-03-3100007667042020-03-012020-03-310000766704srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate201613Member2019-12-310000766704srt:MinimumMemberwell:SeniorsHousingOperatingMember2021-03-310000766704srt:MaximumMemberwell:SeniorsHousingOperatingMember2021-03-310000766704well:SeniorsHousingOperatingMember2021-03-310000766704well:SeniorsHousingOperatingMember2020-12-310000766704well:TripleNetMembersrt:MinimumMember2021-03-310000766704well:TripleNetMembersrt:MaximumMember2021-03-310000766704well:TripleNetMember2021-03-310000766704well:TripleNetMember2020-12-310000766704srt:MinimumMemberwell:OutpatientMedicalMember2021-03-310000766704srt:MaximumMemberwell:OutpatientMedicalMember2021-03-310000766704well:OutpatientMedicalMember2021-03-310000766704well:OutpatientMedicalMember2020-12-310000766704us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2021-03-310000766704well:NetOperatingingIncomeMemberwell:SunriseMember2021-03-310000766704well:NetOperatingingIncomeMemberwell:SunriseMember2021-01-012021-03-310000766704well:NetOperatingingIncomeMemberwell:ProMedicaMember2021-03-310000766704well:NetOperatingingIncomeMemberwell:ProMedicaMember2021-01-012021-03-310000766704well:NetOperatingingIncomeMemberwell:GenesisHealthCareCorporationMember2021-03-310000766704well:NetOperatingingIncomeMemberwell:GenesisHealthCareCorporationMember2021-01-012021-03-310000766704well:NetOperatingingIncomeMemberwell:ReveraMember2021-03-310000766704well:NetOperatingingIncomeMemberwell:ReveraMember2021-01-012021-03-310000766704well:AveryHealthcareMemberwell:NetOperatingingIncomeMember2021-03-310000766704well:AveryHealthcareMemberwell:NetOperatingingIncomeMember2021-01-012021-03-310000766704well:NetOperatingingIncomeMemberwell:RemainingPortfolioMember2021-03-310000766704well:NetOperatingingIncomeMemberwell:RemainingPortfolioMember2021-01-012021-03-310000766704well:NetOperatingingIncomeMember2021-03-310000766704well:NetOperatingingIncomeMember2021-01-012021-03-310000766704us-gaap:SubsequentEventMemberwell:GenesisHealthCareCorporationMemberwell:TripleNetMember2021-04-012021-04-290000766704well:GenesisHealthCareCorporationMemberus-gaap:SubsequentEventMemberwell:ProMedicaMember2021-04-290000766704well:GenesisHealthCareCorporationMemberus-gaap:SubsequentEventMember2021-04-290000766704us-gaap:SubsequentEventMemberwell:GenesisPropertiesMember2021-04-012021-04-290000766704us-gaap:SubsequentEventMemberwell:GenesisHealthCareCorporationMember2021-04-012021-04-29well:term0000766704us-gaap:SubsequentEventMemberwell:TripleNetMember2021-04-290000766704us-gaap:SubsequentEventMemberwell:GenesisHealthCareCorporationMember2021-04-290000766704well:GenesisHealthCareCorporationMember2021-03-31well:bank0000766704us-gaap:RevolvingCreditFacilityMember2021-03-310000766704well:TermCreditFacilityMember2021-03-310000766704well:TermCreditFacilityCADDenominatedMember2021-03-310000766704us-gaap:RevolvingCreditFacilityMemberwell:AccordionfeaturememberMember2021-03-310000766704well:TermCreditFacilityCADDenominatedMemberwell:AccordionfeaturememberMember2021-03-310000766704us-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:RevolvingCreditFacilityMember2021-01-012021-03-310000766704us-gaap:RevolvingCreditFacilityMember2021-01-012021-03-310000766704us-gaap:CommercialPaperMembersrt:MaximumMember2019-01-012019-01-310000766704us-gaap:CommercialPaperMember2019-01-310000766704us-gaap:CommercialPaperMember2021-03-310000766704us-gaap:UnsecuredDebtMember2021-03-310000766704us-gaap:SecuredDebtMember2021-03-310000766704us-gaap:UnsecuredDebtMembersrt:MinimumMember2021-03-310000766704us-gaap:UnsecuredDebtMembersrt:MaximumMember2021-03-310000766704us-gaap:SecuredDebtMembersrt:MinimumMember2021-03-310000766704us-gaap:SecuredDebtMembersrt:MaximumMember2021-03-310000766704us-gaap:UnsecuredDebtMemberwell:UnsecuredTermCreditFacilityDueApril2022Member2021-03-310000766704us-gaap:UnsecuredDebtMemberus-gaap:LondonInterbankOfferedRateLIBORMemberwell:UnsecuredTermCreditFacilityDueApril2022Member2021-01-012021-03-310000766704us-gaap:UnsecuredDebtMemberus-gaap:LondonInterbankOfferedRateLIBORMemberwell:UnsecuredTermCreditFacilityDueApril2022Member2021-03-31iso4217:CAD0000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMember2021-03-310000766704us-gaap:UnsecuredDebtMemberwell:CanadianDealerOfferedRateMemberwell:TermLoanMember2021-01-012021-03-310000766704us-gaap:UnsecuredDebtMemberwell:CanadianDealerOfferedRateMemberwell:TermLoanMember2021-03-310000766704us-gaap:UnsecuredDebtMemberwell:UnsecuredTermCreditFacilityMaturesJuly192023Member2021-03-310000766704us-gaap:UnsecuredDebtMemberus-gaap:LondonInterbankOfferedRateLIBORMemberwell:UnsecuredTermCreditFacilityMaturesJuly192023Member2021-01-012021-03-310000766704us-gaap:UnsecuredDebtMemberus-gaap:LondonInterbankOfferedRateLIBORMemberwell:UnsecuredTermCreditFacilityMaturesJuly192023Member2021-03-310000766704us-gaap:UnsecuredDebtMemberwell:A295SeniorUnsecuredNotesDue2023Member2021-03-310000766704us-gaap:UnsecuredDebtMemberwell:UkDebtDue2028Member2021-03-310000766704us-gaap:UnsecuredDebtMemberwell:A450SeniorUnsecuredNotesDue2034Member2021-03-310000766704us-gaap:UnsecuredDebtMember2020-12-310000766704us-gaap:UnsecuredDebtMember2019-12-310000766704us-gaap:UnsecuredDebtMember2021-01-012021-03-310000766704us-gaap:UnsecuredDebtMember2020-01-012020-03-310000766704us-gaap:UnsecuredDebtMember2020-03-310000766704us-gaap:SecuredDebtMember2020-12-310000766704us-gaap:SecuredDebtMember2019-12-310000766704us-gaap:SecuredDebtMember2021-01-012021-03-310000766704us-gaap:SecuredDebtMember2020-01-012020-03-310000766704us-gaap:SecuredDebtMember2020-03-310000766704us-gaap:UnsecuredDebtMemberwell:A280SeniorUnsecuredNotesDueJune2031Member2021-03-250000766704us-gaap:UnsecuredDebtMemberus-gaap:SubsequentEventMemberwell:A375SeniorUnsecuredNotesDueMarch2023Member2021-04-152021-04-150000766704us-gaap:UnsecuredDebtMemberus-gaap:SubsequentEventMemberwell:A375SeniorUnsecuredNotesDueMarch2023Member2021-04-150000766704us-gaap:UnsecuredDebtMemberwell:A395SeniorUnsecuredNotesDueSeptember2023Memberus-gaap:SubsequentEventMember2021-04-152021-04-150000766704us-gaap:UnsecuredDebtMemberwell:A395SeniorUnsecuredNotesDueSeptember2023Memberus-gaap:SubsequentEventMember2021-04-150000766704us-gaap:UnsecuredDebtMemberus-gaap:SubsequentEventMember2021-04-152021-04-150000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2021-03-310000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2020-12-310000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:GBP2021-03-310000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:GBP2020-12-310000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2021-01-012021-03-310000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2020-01-012020-12-310000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:GBP2021-01-012021-03-310000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:GBP2020-01-012020-12-310000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMembercurrency:USD2021-03-310000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMembercurrency:USD2020-12-310000766704us-gaap:NondesignatedMembercurrency:USD2021-03-310000766704us-gaap:NondesignatedMembercurrency:USD2020-12-310000766704us-gaap:ShortMembercurrency:CADus-gaap:NondesignatedMember2021-03-310000766704us-gaap:ShortMembercurrency:CADus-gaap:NondesignatedMember2020-12-310000766704us-gaap:LongMembercurrency:GBPus-gaap:NondesignatedMember2021-03-310000766704us-gaap:LongMembercurrency:GBPus-gaap:NondesignatedMember2020-12-310000766704us-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-03-310000766704us-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-03-310000766704us-gaap:NondesignatedMember2021-01-012021-03-310000766704us-gaap:NondesignatedMember2020-01-012020-03-310000766704us-gaap:ForeignExchangeContractMember2020-01-012020-03-31well:obligation0000766704well:EquityShelfProgramMember2019-02-280000766704well:EquityShelfProgramMember2021-03-310000766704us-gaap:EmployeeStockOptionMember2021-01-012021-03-310000766704well:RepurchaseProgramMember2020-05-010000766704us-gaap:AccumulatedTranslationAdjustmentMember2021-03-310000766704us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310000766704us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-03-310000766704us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-12-310000766704us-gaap:MortgagesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-03-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MortgagesMember2021-03-310000766704us-gaap:MortgagesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-12-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MortgagesMember2020-12-310000766704well:OtherRealEstateLoansReceivableMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-03-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberwell:OtherRealEstateLoansReceivableMember2021-03-310000766704well:OtherRealEstateLoansReceivableMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-12-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberwell:OtherRealEstateLoansReceivableMember2020-12-310000766704us-gaap:FairValueInputsLevel1Member2021-03-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-03-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMember2020-12-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMember2021-03-310000766704well:NonRealEstateLoansReceivablesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-03-310000766704well:NonRealEstateLoansReceivablesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-03-310000766704well:NonRealEstateLoansReceivablesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-12-310000766704well:NonRealEstateLoansReceivablesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310000766704us-gaap:FairValueInputsLevel2Member2021-03-310000766704us-gaap:FairValueInputsLevel3Member2021-03-31well:segment0000766704well:SeniorHousingOperatingMemberus-gaap:ManagementServiceMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000766704us-gaap:ManagementServiceMemberwell:TripleNetMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000766704well:OutpatientMedicalMemberus-gaap:ManagementServiceMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000766704us-gaap:CorporateNonSegmentMemberus-gaap:ManagementServiceMember2021-01-012021-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000766704well:TripleNetMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000766704us-gaap:CorporateNonSegmentMember2021-01-012021-03-310000766704well:SeniorHousingOperatingMemberwell:InterestRevenueMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000766704well:InterestRevenueMemberwell:TripleNetMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000766704well:InterestRevenueMemberwell:OutpatientMedicalMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000766704well:InterestRevenueMemberus-gaap:CorporateNonSegmentMember2021-01-012021-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMember2021-01-012021-03-310000766704well:TripleNetMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMember2021-01-012021-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMember2021-01-012021-03-310000766704us-gaap:CorporateNonSegmentMemberus-gaap:ProductAndServiceOtherMember2021-01-012021-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMember2021-03-310000766704well:TripleNetMemberus-gaap:OperatingSegmentsMember2021-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMember2021-03-310000766704well:SeniorHousingOperatingMemberus-gaap:ManagementServiceMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310000766704us-gaap:ManagementServiceMemberwell:TripleNetMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310000766704well:OutpatientMedicalMemberus-gaap:ManagementServiceMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310000766704us-gaap:CorporateNonSegmentMemberus-gaap:ManagementServiceMember2020-01-012020-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310000766704well:TripleNetMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310000766704us-gaap:CorporateNonSegmentMember2020-01-012020-03-310000766704well:SeniorHousingOperatingMemberwell:InterestRevenueMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310000766704well:InterestRevenueMemberwell:TripleNetMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310000766704well:InterestRevenueMemberwell:OutpatientMedicalMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310000766704well:InterestRevenueMemberus-gaap:CorporateNonSegmentMember2020-01-012020-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMember2020-01-012020-03-310000766704well:TripleNetMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMember2020-01-012020-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMember2020-01-012020-03-310000766704us-gaap:CorporateNonSegmentMemberus-gaap:ProductAndServiceOtherMember2020-01-012020-03-310000766704country:US2021-01-012021-03-310000766704country:USus-gaap:SalesRevenueNetMember2021-01-012021-03-310000766704country:US2020-01-012020-03-310000766704country:USus-gaap:SalesRevenueNetMember2020-01-012020-03-310000766704country:GB2021-01-012021-03-310000766704country:GBus-gaap:SalesRevenueNetMember2021-01-012021-03-310000766704country:GB2020-01-012020-03-310000766704country:GBus-gaap:SalesRevenueNetMember2020-01-012020-03-310000766704country:CA2021-01-012021-03-310000766704country:CAus-gaap:SalesRevenueNetMember2021-01-012021-03-310000766704country:CA2020-01-012020-03-310000766704country:CAus-gaap:SalesRevenueNetMember2020-01-012020-03-310000766704us-gaap:SalesRevenueNetMember2021-01-012021-03-310000766704us-gaap:SalesRevenueNetMember2020-01-012020-03-310000766704country:US2021-03-310000766704us-gaap:AssetsTotalMembercountry:US2021-01-012021-03-310000766704country:US2020-12-310000766704us-gaap:AssetsTotalMembercountry:US2020-01-012020-12-310000766704country:GB2021-03-310000766704us-gaap:AssetsTotalMembercountry:GB2021-01-012021-03-310000766704country:GB2020-12-310000766704us-gaap:AssetsTotalMembercountry:GB2020-01-012020-12-310000766704country:CA2021-03-310000766704country:CAus-gaap:AssetsTotalMember2021-01-012021-03-310000766704country:CA2020-12-310000766704country:CAus-gaap:AssetsTotalMember2020-01-012020-12-310000766704us-gaap:AssetsTotalMember2021-01-012021-03-310000766704us-gaap:AssetsTotalMember2020-01-012020-12-310000766704country:USus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2021-01-012021-03-310000766704us-gaap:ManagementServiceMembercountry:GBus-gaap:SalesRevenueNetMember2021-01-012021-03-310000766704country:CAus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2021-01-012021-03-310000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-03-310000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2020-12-31

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
   
 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2021
or
   
 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                     to                      
Commission file number: 1-8923
WELLTOWER INC.
 
(Exact name of registrant as specified in its charter
Delaware34-1096634
(State or other jurisdiction
of Incorporation)
(IRS Employer
Identification No.)
4500 Dorr StreetToledo,Ohio43615
(Address of principal executive offices)(Zip Code)
(419)247-2800
(Registrant’s telephone number, including area code)  
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, $1.00 par value per shareWELLNew York Stock Exchange
4.800% Notes due 2028WELL28New York Stock Exchange
4.500% Notes due 2034WELL34New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  þ  No  ¨
Indicate by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ  No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 þ
 Accelerated filer
¨
 Non-accelerated filer
¨
 Smaller reporting company
Emerging growth company
(Do not check if a smaller reporting company)
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No  þ
As of April 23, 2021, the registrant had 417,520,500 shares of common stock outstanding. 



TABLE OF CONTENTS
 
 Page
PART I. FINANCIAL INFORMATION 
  
Item 1. Financial Statements (Unaudited)
  
Consolidated Balance Sheets
  
Consolidated Statements of Comprehensive Income
  
Consolidated Statements of Equity
  
Consolidated Statements of Cash Flows
  
Notes to Unaudited Consolidated Financial Statements
  
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
  
Item 3. Quantitative and Qualitative Disclosures About Market Risk
  
Item 4. Controls and Procedures
  
PART II. OTHER INFORMATION 
  
Item 1. Legal Proceedings
  
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
  
Item 5. Other Information
  
Item 6. Exhibits
  
Signatures



PART I. FINANCIAL INFORMATION
Item 1. Financial Statements 

CONSOLIDATED BALANCE SHEETS
WELLTOWER INC. AND SUBSIDIARIES
(In thousands) 
March 31, 2021 (Unaudited)December 31, 2020 (Note)
Assets:  
  
Real estate investments:  
  
Real property owned:  
Land and land improvements  
$3,397,055 $3,440,650 
Buildings and improvements  
27,667,188 28,024,971 
Acquired lease intangibles  
1,506,823 1,500,030 
Real property held for sale, net of accumulated depreciation  
564,062 216,613 
Construction in progress  
542,302 487,742 
Less accumulated depreciation and amortization  
(6,212,432)(6,104,297)
Net real property owned  
27,464,998 27,565,709 
Right of use assets, net454,787 465,866 
Real estate loans receivable, net of credit allowance  487,674 443,372 
Net real estate investments  28,407,459 28,474,947 
Other assets:  
Investments in unconsolidated entities  
1,020,010 946,234 
Goodwill  
68,321 68,321 
Cash and cash equivalents  
2,131,846 1,545,046 
Restricted cash  
426,976 475,997 
Straight-line rent receivable
312,721 344,066 
Receivables and other assets  
624,918 629,031 
Total other assets  
4,584,792 4,008,695 
Total assets  
$32,992,251 $32,483,642 
Liabilities and equity  
Liabilities:  
Senior unsecured notes  
$12,183,710 $11,420,790 
Secured debt  
2,329,474 2,377,930 
Lease liabilities
408,916 418,266 
Accrued expenses and other liabilities  
1,023,219 1,041,594 
Total liabilities  
15,945,319 15,258,580 
Redeemable noncontrolling interests  
355,915 343,490 
Equity:  
Common stock  
418,866 418,691 
Capital in excess of par value  
20,814,196 20,823,145 
Treasury stock  
(106,519)(104,490)
Cumulative net income  
8,399,144 8,327,598 
Cumulative dividends  
(13,598,673)(13,343,721)
Accumulated other comprehensive income (loss)  
(128,136)(148,504)
Total Welltower Inc. stockholders’ equity  
15,798,878 15,972,719 
Noncontrolling interests  
892,139 908,853 
Total equity  
16,691,017 16,881,572 
Total liabilities and equity  
$32,992,251 $32,483,642 
Note: The consolidated balance sheet at December 31, 2020 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

3


CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands, except per share data) 
Three Months Ended
March 31,
 20212020
Revenues:
Resident fees and services
$723,464  $849,972 
Rental income  
302,843 389,960 
Interest income
19,579 15,241 
Other income
6,176 3,429 
Total revenues
1,052,062 1,258,602 
Expenses:
Property operating expenses
617,326 681,781 
Depreciation and amortization
244,426 274,801 
Interest expense
123,142 142,007 
General and administrative expenses
29,926 35,481 
Loss (gain) on derivatives and financial instruments, net
1,934 7,651 
Loss (gain) on extinguishment of debt, net
(4,643) 
Provision for loan losses
1,383 7,072 
Impairment of assets
23,568 27,827 
Other expenses
10,994 6,292 
Total expenses
1,048,056 1,182,912 
Income (loss) from continuing operations before income taxes and other items4,006 75,690 
Income tax (expense) benefit(3,943)(5,442)
Income (loss) from unconsolidated entities13,049 (3,692)
Gain (loss) on real estate dispositions, net59,080 262,824 
Income (loss) from continuing operations72,192 329,380 
Net income72,192 329,380 
Less: Net income (loss) attributable to noncontrolling interests(1)
646 19,096 
Net income (loss) attributable to common stockholders$71,546 $310,284 
Average number of common shares outstanding:
Basic
417,241 410,306 
Diluted
419,079 412,420 
Earnings per share:
Basic:
Income (loss) from continuing operations
$0.17 $0.80 
Net income (loss) attributable to common stockholders
$0.17 $0.76 
Diluted:
Income (loss) from continuing operations
$0.17 $0.80 
Net income (loss) attributable to common stockholders(2)
$0.17 $0.75 
Dividends declared and paid per common share$0.61 $0.87 
(1) Includes amounts attributable to redeemable noncontrolling interests.
(2) Includes adjustment to the numerator for income (loss) attributable to OP unitholders.


4


CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands) 
 Three Months Ended
March 31,
 20212020
Net income$72,192 $329,380 
Other comprehensive income (loss):
Foreign currency translation gain (loss)44,210 (265,577)
Derivative and financial instruments designated as hedges gain (loss)(20,037)259,112 
Total other comprehensive income (loss)24,173 (6,465)
Total comprehensive income (loss)96,365 322,915 
Less: Total comprehensive income (loss) attributable
to noncontrolling interests(1)
4,451 (3,313)
Total comprehensive income (loss) attributable to common stockholders$91,914 $326,228 
(1) Includes amounts attributable to redeemable noncontrolling interests.

5


CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
Three Months Ended March 31, 2021
Common
Stock
Capital in
Excess of
Par Value
Treasury
Stock
Cumulative
Net Income
Cumulative
Dividends
Accumulated Other
Comprehensive
Income (Loss)
Noncontrolling
Interests
Total
Balances at January 1, 2021$418,691 $20,823,145 $(104,490)$8,327,598 $(13,343,721)$(148,504)$908,853 $16,881,572 
Comprehensive income:
Net income (loss)
71,546 (177)71,369 
Other comprehensive income (loss)
20,368 3,729 24,097 
Total comprehensive income95,466 
Net change in noncontrolling interests(14,250)(20,266)(34,516)
Amounts related to stock incentive plans, net of forfeitures175 5,393 (2,029)3,539 
Net proceeds from issuance of common stock(92)(92)
Dividends paid:
Common stock dividends
(254,952)(254,952)
Balances at March 31, 2021$418,866 $20,814,196 $(106,519)$8,399,144 $(13,598,673)$(128,136)$892,139 $16,691,017 
 Three Months Ended March 31, 2020
 Common
Stock
Capital in
Excess of
Par Value
Treasury
Stock
Cumulative
Net Income
Cumulative
Dividends
Accumulated Other
Comprehensive
Income (Loss)
Noncontrolling
Interests
Total
Balances at January 1, 2020$411,005 $20,190,119 $(78,955)$7,353,966 $(12,223,534)$(112,157)$966,183 $16,506,627 
Cumulative change in accounting principle (Note 2)(5,212)(5,212)
Balances at January 1, 2020 (as adjusted for change in accounting principle)411,005 20,190,119 (78,955)7,348,754 (12,223,534)(112,157)966,183 16,501,415 
Comprehensive income:
Net income (loss)
310,284 18,988 329,272 
Other comprehensive income (loss)
15,944 (21,955)(6,011)
Total comprehensive income323,261 
Net change in noncontrolling interests37,625 (29,662)7,963 
Amounts related to stock incentive plans, net of forfeitures246 6,608 (8,020)(1,166)
Net proceeds from issuance of common stock6,975 583,890 590,865 
Dividends paid:
Common stock dividends
(356,001)(356,001)
Balances at March 31, 2020$418,226 $20,818,242 $(86,975)$7,659,038 $(12,579,535)$(96,213)$933,554 $17,066,337 

6


CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
Three Months Ended
March 31,
 20212020
Operating activities:    
Net income  $72,192 $329,380 
Adjustments to reconcile net income to net cash provided from (used in) operating activities:  
Depreciation and amortization  
244,426 274,801 
Other amortization expenses  
4,197 3,220 
Provision for loan losses
1,383 7,072 
Impairment of assets  
23,568 27,827 
Stock-based compensation expense  
5,576 7,083 
Loss (gain) on derivatives and financial instruments, net  
1,934 7,651 
Loss (gain) on extinguishment of debt, net  
(4,643) 
Loss (income) from unconsolidated entities
(13,049)3,692 
Rental income less than (in excess of) cash received  
30,563 (2,119)
Amortization related to above (below) market leases, net  
(460)(565)
Loss (gain) on real estate dispositions, net  
(59,080)(262,824)
Distributions by unconsolidated entities
3,036 3,385 
Increase (decrease) in accrued expenses and other liabilities  
(4,406)(30,030)
Decrease (increase) in receivables and other assets  
(1,579)43,284 
Net cash provided from (used in) operating activities  303,658 411,857 
 
Investing activities:  
Cash disbursed for acquisitions, net of cash acquired
(203,107)(390,802)
Cash disbursed for capital improvements to existing properties
(28,780)(69,382)
Cash disbursed for construction in progress
(73,605)(48,775)
Capitalized interest  
(4,496)(4,746)
Investment in loans receivable
(43,148)(10,441)
Principal collected on loans receivable  
2,852 10,045 
Other investments, net of payments  
664 (3,612)
Contributions to unconsolidated entities  
(94,095)(137,129)
Distributions by unconsolidated entities  
36,934 3,555 
Proceeds from (payments on) derivatives  
(6,567)(357)
Proceeds from sales of real property  
274,208 801,392 
Net cash provided from (used in) investing activities  (139,140)149,748 
Financing activities:  
Net increase (decrease) under unsecured credit facility and commercial paper
 (742,612)
Net proceeds from issuance of senior unsecured notes713,907  
Net proceeds from the issuance of secured debt  
 44,921 
Payments on secured debt  
(57,888)(31,566)
Net proceeds from the issuance of common stock  
 591,001 
Payments for deferred financing costs and prepayment penalties  
(1,221)(722)
Contributions by noncontrolling interests(1)
5,073 9,084 
Distributions to noncontrolling interests(1)
(30,117)(50,124)
Cash distributions to stockholders  
(254,915)(354,678)
Other financing activities
(2,936)(9,599)
Net cash provided from (used in) financing activities  371,903 (544,295)
Effect of foreign currency translation on cash and cash equivalents and restricted cash1,358 (10,010)
Increase (decrease) in cash, cash equivalents and restricted cash  537,779 7,300 
Cash, cash equivalents and restricted cash at beginning of period  2,021,043 385,766 
Cash, cash equivalents and restricted cash at end of period  $2,558,822 $393,066 
Supplemental cash flow information:
Interest paid$135,947 $140,216 
Income taxes paid (received), net(852)471 
(1) Includes amounts attributable to redeemable noncontrolling interests.

7

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

1. Business
Welltower Inc. (the "Company"), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience. Welltower™, a real estate investment trust (“REIT”), owns interests in properties concentrated in major, high-growth markets in the United States (“U.S.”), Canada and the United Kingdom (“U.K.”), consisting of seniors housing and post-acute communities and outpatient medical properties. 
2. Accounting Policies and Related Matters
Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (such as normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2021 are not necessarily an indication of the results that may be expected for the year ending December 31, 2021. For further information, refer to the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2020.
Impact of COVID-19 Pandemic
The extent to which the COVID-19 pandemic impacts our operations and those of our operators and tenants will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the scope, severity and duration of the pandemic, the actions taken to contain the pandemic or mitigate its impact and the direct and indirect economic effects of the pandemic and containment measures, among others. The COVID-19 pandemic could have material and adverse effects on our financial condition, results of operations and cash flows in the future, including but not limited to, the following:
Our Seniors Housing Operating revenues are dependent on occupancy. Spot occupancy has continued to decline since the beginning of the pandemic, dropping to 73.6% as of March 31, 2021 compared to 75.9% as of December 31, 2020. Approximately 99% of communities are currently accepting new residents, resulting in an acceleration in move-in activity and an increase in occupancy of approximately 60 basis points from a pandemic-low on March 12, 2021 to 73.8% on April 23, 2021. Additionally, rapid distribution and a high acceptance rate of COVID-19 vaccinations by residents within assisted living and memory care facilities in the U.S. and U.K. has resulted in a significant decrease in total resident case counts since mid-January 2021 across the portfolio. Spot occupancy rates from the start of the pandemic through March 31, 2021 are as follows:
February 2020December 2020January 2021February 2021March 2021
Spot occupancy (1)
85.4 %75.9 %74.4 %73.6 %73.6 %
Sequential occupancy change(1.5)%(0.8)% %
(1) Spot occupancy represents approximate month end occupancy at our share for properties in operation as of February 29, 2020, including unconsolidated properties but excluding acquisitions, dispositions and development conversions since this date.

Increased Seniors Housing Operating expenses are expected to continue until the pandemic subsides. Property-level operating expenses associated with the COVID-19 pandemic relating to our Seniors Housing Operating portfolio, net of reimbursements including Provider Relief Funds and similar programs in the U.K. and Canada, resulted in a benefit of approximately $21,204,000 for the three months ended March 31, 2021 as compared to an expense of $7,294,000 during the three months ended March 31, 2020. These expenses were incurred as a result of the introduction of public health measures and other regulations affecting our properties, as well as additional health and safety measures adopted by us and our operators related to the COVID-19 pandemic, including increases in labor and property cleaning expenses and expenditures related to our efforts to procure personal protective equipment ("PPE") and supplies, net of reimbursements. Certain new expenses incurred since the start of the pandemic may continue on an ongoing basis as part of new health and safety protocols.
In 2020 applications were made for amounts under Phase 2 and Phase 3 of the Provider Relief Fund related to our Seniors Housing Operating portfolio. During the first quarter, we received total Provider Relief Funds of approximately $35,682,000, which was recognized as a reduction to COVID-19 costs within property operating expenses.
8

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Our Triple-net operators are experiencing similar occupancy declines and operating costs as described above with respect to our Seniors Housing Operating properties. Additionally, long-term/post-acute care facilities are generally experiencing a higher degree of occupancy declines. These factors may continue to impact the ability of our Triple-net operators to make contractual rent payments to us in the future. Many of our Triple-net operators received funds under the Coronavirus Aid Relief and Economic Security Act (“CARES Act”) Paycheck Protection Program. In addition, operators of long-term/post-acute care facilities have generally received funds from Phase 1 of the Provider Relief Fund and operators of assisted living facilities have generally received funds from Phases 2 and 3 of the Provider Relief Fund.
During the first quarter, we collected approximately 96% of rent due from operators under Triple-net lease agreements (primarily seniors housing and post-acute care facilities). No significant rent deferrals or rent concessions have been made. In the Outpatient Medical segment we collected 99% of rent due in the first quarter, with uncollected amounts primarily attributable to local jurisdictions with COVID-19 related ordinances providing temporary rent relief to tenants. Virtually all rent subject to approved deferral agreements has been repaid in full. For both our Triple-net operators and Outpatient Medical tenants, we evaluate leases individually and recognize rent on a cash basis if collectibility of substantially all contractual rent payments is not probable. To the extent the prolonged impact of the COVID-19 pandemic causes operators or tenants to seek further modifications of their lease agreements, we may recognize reductions in revenue and increases in uncollectible receivables.
New Accounting Standards   
In August 2020, the FASB issued ASU 2020-06, “Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40) Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”. This ASU simplifies accounting for convertible instruments and removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception. This ASU also simplifies the diluted earnings per share calculation in certain areas and provides updated disclosure requirements. The ASU is effective for public business entities beginning after December 15, 2021 including interim periods within those fiscal years. Early adoption is permitted. We are currently evaluating the guidance and the impact it may have on our consolidated financial statements.
In March 2020, the FASB issued an amendment to the reference rate reform standard which provides the option for a limited period of time to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on contract modifications and hedge accounting. An example of such reform is the expected market transition from the London Interbank Offered Rate ("LIBOR") and other interbank offered rates to alternative reference rates. Entities that make this optional expedient election would not have to remeasure the contracts at the modification date or reassess the accounting treatment if certain criteria are met and would continue applying hedge accounting for relationships affected by reference rate reform. The new standard was effective for us upon issuance and elections can be made through December 31, 2022. We are currently evaluating our options with regards to existing contracts and hedging relationships and the impact of adopting this update on our consolidated financial statements.
3. Real Property Acquisitions and Development 
The total purchase price for all properties acquired has been allocated to the tangible and identifiable intangible assets and liabilities at cost on a relative fair value basis. Liabilities assumed and any associated noncontrolling interests are reflected at fair value. The results of operations for these acquisitions have been included in our consolidated results of operations since the date of acquisition and are a component of the appropriate segments. Transaction costs primarily represent costs incurred with acquisitions, including due diligence costs, fees for legal and valuation services, termination of pre-existing relationships computed based on the fair value of the assets acquired, lease termination fees and other acquisition-related costs. Transaction costs related to asset acquisitions are capitalized as a component of purchase price and all other non-capitalizable costs are reflected in other expenses on our Consolidated Statements of Comprehensive Income.
The following is a summary of our real property investment activity by segment for the periods presented (in thousands):
9

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
 Three Months Ended
 March 31, 2021March 31, 2020
Seniors Housing OperatingTriple-netOutpatient
Medical
TotalsSeniors Housing OperatingTriple-netOutpatient
Medical
Totals
Land and land improvements$1,240 $24,154 $2,273 $27,667 $15,758 $ $40,847 $56,605 
Buildings and improvements3,491 170,362 10,570 184,423 132,480 765 171,457 304,702 
Acquired lease intangibles339  1,439 1,778 10,810  23,823 34,633 
Receivables and other assets34   34 257  139 396 
Total assets acquired (1)
5,104 194,516 14,282 213,902 159,305 765 236,266 396,336 
Accrued expenses and other liabilities (8,703)(36)(8,739)(671) (2,036)(2,707)
Total liabilities acquired (8,703)(36)(8,739)(671) (2,036)(2,707)
Noncontrolling interests (2)
 (2,056) (2,056)(2,827)  (2,827)
Cash disbursed for acquisitions5,104 183,757 14,246 203,107 155,807 765 234,230 390,802 
Construction in progress additions38,373 31,809 7,601 77,783 29,841 13,929 13,645 57,415 
Less: Capitalized interest(2,980)(524)(992)(4,496)(2,812)(941)(993)(4,746)
Accruals (3)
7  311 318 (2,600) (1,294)(3,894)
Cash disbursed for construction in progress35,400 31,285 6,920 73,605 24,429 12,988 11,358 48,775 
Capital improvements to existing properties(3,159)25,295 6,644 28,780 52,503 3,248 13,631 69,382 
Total cash invested in real property, net of cash acquired$37,345 $240,337 $27,810 $305,492 $232,739 $17,001 $259,219 $508,959 
(1) Excludes $580,000 of unrestricted and restricted cash acquired during the three months ended March 31, 2020.
(2) Includes amounts attributable to both redeemable noncontrolling interests and noncontrolling interests.
(3) Represents non-cash accruals for amounts to be paid in future periods for properties that converted, off-set by amounts paid in the current period.
Construction Activity 
The following is a summary of the construction projects that were placed into service and began generating revenues during the periods presented (in thousands):
 Three Months Ended
 March 31, 2021March 31, 2020
Development projects:
Seniors Housing Operating
$ $93,188 
Triple-net
22,990  
Outpatient Medical
 19,369 
Total construction in progress conversions$22,990 $112,557 
4. Real Estate Intangibles 
The following is a summary of our real estate intangibles, excluding those classified as held for sale, as of the dates indicated (dollars in thousands):
 March 31, 2021December 31, 2020
Assets:
In place lease intangibles$1,411,060 $1,406,705 
Above market tenant leases53,066 52,621 
Lease commissions42,697 40,704 
Gross historical cost1,506,823 1,500,030 
Accumulated amortization(1,204,529)(1,177,513)
Net book value$302,294 $322,517 
Weighted-average amortization period in years10.710.5
Liabilities:
Below market tenant leases$75,451 $77,851 
Accumulated amortization(40,542)(40,871)
Net book value$34,909 $36,980 
Weighted-average amortization period in years8.28.3
10

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
The following is a summary of real estate intangible amortization income (expense) for the periods presented (in thousands):
Three Months Ended March 31,
20212020
Rental income related to (above)/below market tenant leases, net$425 $524 
Amortization related to in place lease intangibles and lease commissions(22,779)(35,976)
The future estimated aggregate amortization of intangible assets and liabilities is as follows for the periods presented (in thousands):
 AssetsLiabilities
2021$55,162 $5,945 
202244,266 7,304 
202334,588 5,153 
202426,981 3,047 
202521,712 2,482 
Thereafter119,585 10,978 
Total$302,294 $34,909 
5. Dispositions, Real Property Held for Sale and Impairment
We periodically sell properties for various reasons, including favorable market conditions, the exercise of tenant purchase options or reduction of concentrations (i.e., property type, relationship or geography). At March 31, 2021, three Seniors Housing Operating, 61 Triple-net, and one Outpatient Medical properties with an aggregate real estate balance of $564,062,000 were classified as held for sale. In addition to the real property balances held for sale, net other assets and (liabilities) of $37,389,000 are included in the Consolidated Balance Sheet related to the held for sale properties. Expected gross sales proceeds related to the held for sale properties is approximately $716,835,000.
During the three months ended March 31, 2021, we recorded $12,098,000 of impairment charges related to one Triple-net property which was classified as held for sale for which the carrying value exceeded the estimated fair value less cost to sell. Additionally, during the three months ended March 31, 2021, we recorded $11,470,000 of impairment charges related to one Seniors Housing Operating property and two Triple-net properties that were held for use in which the carrying value exceeded the estimated fair value. During the three months ended March 31, 2020, we recorded $3,495,000 of impairment charges related to one Seniors Housing Operating property which was classified as held for sale for which the carrying value exceeded the estimated fair value less cost to sell. Additionally, during the three months ended March 31, 2020, we recorded $24,332,000 of impairment charges related to two Triple-net properties that were held for use in which the carrying value exceeded the estimated fair value.
The following is a summary of our real property disposition activity for the periods presented (in thousands):
 Three Months Ended March 31,
 20212020
Real estate dispositions:
Seniors Housing Operating
$74,326 $ 
Triple-net
 33,445 
Outpatient Medical
137,890 495,003 
Total dispositions
212,216 528,448 
Gain (loss) on real estate dispositions, net59,080 262,824 
Net other assets/liabilities disposed
2,912 10,120 
Proceeds from real estate dispositions$274,208 $801,392 
Operating results attributable to properties sold or classified as held for sale which do not meet the definition of discontinued operations are not reclassified on our Consolidated Statements of Comprehensive Income. The following represents the activity related to these properties for the periods presented (in thousands):
11

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Three Months Ended March 31,
 20212020
Revenues:
Total revenues
$21,024 $136,452 
Expenses:
Interest expense
17 3,806 
Property operating expenses
(1,102)61,315 
Provision for depreciation
4,567 23,708 
Total expenses
3,482 88,829 
Income (loss) from real estate dispositions, net$17,542 $47,623 
6. Leases
We lease land, buildings, office space and certain equipment. Many of our leases include a renewal option to extend the term from one to 25 years or more. Renewal options that we are reasonably certain to exercise are recognized in our right-of-use assets and lease liabilities.
The components of lease expense were as follows for the period presented (in thousands):
Three Months Ended
 ClassificationMarch 31, 2021March 31, 2020
Operating lease cost: (1)
Real estate lease expenseProperty operating expenses$5,358 $6,492 
Non-real estate investment lease expenseGeneral and administrative expenses1,185 1,267 
Finance lease cost:
Amortization of leased assetsProperty operating expenses2,035 2,243 
Interest on lease liabilitiesInterest expense1,663 1,379 
Sublease incomeRental income(1,043)(1,043)
Total $9,198 $10,338 
(1) Includes short-term leases which are immaterial.
Supplemental balance sheet information related to leases is as follows (in thousands):
 ClassificationMarch 31, 2021December 31, 2020
Right of use assets:
Operating leases - real estateRight of use assets, net$301,505 $310,017 
Finance leases - real estateRight of use assets, net153,282 155,849 
Real estate right of use assets, net454,787 465,866 
Operating leases - non-real estate investmentsReceivables and other assets7,886 9,624 
Total right of use assets, net$462,673 $475,490 
Lease liabilities:
Operating leases$303,387 $311,164 
Financing leases105,529 107,102 
Total$408,916 $418,266 
Substantially all of our operating leases in which we are the lessor contain escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectability assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period. During the three months ended March 31, 2021 and 2020, we reserved for straight-line rent receivable balances of $49,241,000 and $32,268,000 through rental income, relating to leases for which collection of substantially all contractual lease payments was no longer deemed probable.
Leases in our Triple-net and Outpatient Medical portfolios typically include some form of operating expense reimbursement by the tenant. For the three months ended March 31, 2021, we recognized $302,843,000 of rental income related to operating leases, of which $46,026,000 was for variable lease payments which primarily represents the reimbursement of operating costs such as common area maintenance expenses, utilities, insurance and real estate taxes. For the three months ended March 31, 2020, we recognized $389,960,000 of rental income related to operating leases, of which $55,754,000 was for variable lease payments.
12

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
7. Loans Receivable
Loans receivable are recorded on our Consolidated Balance Sheets in real estate loans receivable, net of allowance for credit losses, or for non-real estate loans receivable, in receivables and other assets, net of allowance for credit losses. Real estate loans receivable consists of mortgage loans and other real estate loans which are primarily collateralized by a first, second or third mortgage lien, a leasehold mortgage on, or an assignment of the partnership interest in, the related properties, corporate guarantees and/or personal guarantees. Non-real estate loans are generally corporate loans with no real estate backing. Interest income on loans is recognized as earned based upon the principal amount outstanding subject to an evaluation of the risk of credit loss. Accrued interest receivable was $15,981,000 and $15,615,000 as of March 31, 2021 and December 31, 2020, respectively, and is included in receivables and other assets on the Consolidated Balance Sheets. The following is a summary of our loans receivable (in thousands):
 March 31, 2021December 31, 2020
Mortgage loans$338,291 $299,430 
Other real estate loans158,066 152,739 
Allowance for credit losses on real estate loans receivable(8,683)(8,797)
Real estate loans receivable, net of credit allowance487,674 443,372 
Non-real estate loans458,391 455,508 
Allowance for credit losses on non-real estate loans receivable(215,463)(215,239)
Non-real estate loans receivable, net of credit allowance242,928 240,269 
Total loans receivable, net of credit allowance$730,602 $683,641 
The following is a summary of our loan activity for the periods presented (in thousands):    
 Three Months Ended
 March 31, 2021March 31, 2020
Advances on loans receivable:
Investments in new loans
$30,999 $ 
Draws on existing loans
12,149 10,441 
Net cash advances on loans receivable
43,148 10,441 
Receipts on loans receivable:
Loan payoffs
1,620  
Principal payments on loans
1,232 10,045 
Net cash receipts on loans receivable2,852 10,045 
Net cash advances (receipts) on loans receivable$40,296 $396 
Subsequent to quarter end, we provided £540 million of senior loan financing and a £30 million delayed facility to affiliates of Safanad, a global real estate and private equity firm, as part of the recapitalization of its investment in HC-One Group. The loan has a 5-year term and is fully collateralized by the shares and assets of the HC-One Group, including its underlying property portfolio of owned assets across the U.K. Additionally, we will have the ability to participate in the recovery in the U.K. seniors housing sector through both warrants and a £55 million equity investment.
The allowance for credit loss on loans receivable is maintained at a level believed adequate to absorb potential losses in our loans receivable. The determination of the credit allowance is based on a quarterly evaluation of each of these loans, including general economic conditions and estimated collectability of loan payments. We evaluate the collectability of our loans receivable based on a combination of credit quality indicators, including, but not limited to, payment status, historical loan charge-offs, financial strength of the borrower and guarantors, and nature, extent, and value of the underlying collateral.
A loan is considered to have deteriorated credit quality when, based on current information and events, it is probable that we will be unable to collect all amounts due as scheduled according to the contractual terms of the loan agreement. For those loans we identified as having deteriorated credit quality we determine the amount of credit loss on an individual basis. Placement on non-accrual status may be required. Consistent with this definition, all loans on non-accrual are deemed to have deteriorated credit quality. To the extent circumstances improve and the risk of collectability is diminished, we will return these loans to income accrual status. While a loan is on non-accrual status, any cash receipts are applied against the outstanding principal balance.
For the remaining loans we assess credit loss on a collective pool basis and use our historical loss experience for similar loans to determine the reserve for credit losses. The following is a summary of our loans by credit loss category (in thousands):
13

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2021
Loan categoryYears of OriginationLoan Carrying ValueAllowance for Credit LossNet Loan BalanceNo. of Loans
Deteriorated loans2007 - 2018$241,012 $(211,191)$29,821 6 
Collective loan pool2007-2016259,913 (5,061)254,852 18 
Collective loan pool2017126,746 (1,488)125,258 7 
Collective loan pool201820,620 (404)20,216 1 
Collective loan pool201947,045 (923)46,122 7 
Collective loan pool2020229,219 (4,488)224,731 11 
Collective loan pool202130,193 (591)29,602 2 
Total loans$954,748 $(224,146)$730,602 52 
In March 2020, we recognized a provision for loan losses of $6,898,000 to fully reserve for one Triple-net non-real estate loan receivable that was no longer deemed collectible. The following is a summary of the allowance for credit losses on loans receivable for the periods presented (in thousands):                                    
Three Months Ended
March 31, 2021March 31, 2020
Balance at beginning of period$224,036 $68,372 
Adoption of ASU 2016-13— 5,212 
Provision for loan losses1,383 7,072 
Loan write-offs(1,322) 
Foreign currency translation49 (85)
Balance at end of period$224,146 $80,571 
The following is a summary of our deteriorated loans (in thousands):
 Three Months Ended
 March 31, 2021March 31, 2020
Balance of deteriorated loans at end of period (1)
$241,012 $185,982 
Allowance for credit losses(211,191)(75,372)
Balance of deteriorated loans not reserved$29,821 $110,610 
Interest recognized on deteriorated loans (2)
$3,079 $4,046 
(1) Current year amounts include $2,250,000 and $3,623,000 of loans on non-accrual as of March 31, 2021 and December 31, 2020, respectively. Prior year amounts include $9,534,000 and $2,534,000 as of March 31, 2020 and December 31, 2019, respectively.
(2) Represents cash interest recognized in the period.
8. Investments in Unconsolidated Entities
We participate in a number of joint ventures, which generally invest in seniors housing and health care real estate. The results of operations for these properties have been included in our consolidated results of operations from the date of acquisition by the joint ventures and are reflected in our Consolidated Statements of Comprehensive Income as income or loss from unconsolidated entities. The following is a summary of our investments in unconsolidated entities (dollars in thousands): 
 
Percentage Ownership (1)
March 31, 2021December 31, 2020
Seniors Housing Operating
10% to 65%
$709,727 $653,057 
Triple-net
10% to 25%
5,575 5,629 
Outpatient Medical
15% to 50%
304,708 287,548 
Total $1,020,010 $946,234 
(1) Includes ownership of investments classified as liabilities and excludes ownership of in substance real estate.
At March 31, 2021, the aggregate unamortized basis difference of our joint venture investments of $119,392,000 is primarily attributable to the difference between the amount for which we purchase our interest in the entity, including transaction costs, and the historical carrying value of the net assets of the joint venture. This difference is being amortized over the remaining useful life of the related properties and included in the reported amount of income from unconsolidated entities.
14

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

We have made loans totaling $365,488,000 related to eight properties as of March 31, 2021 for the development and construction of certain properties which are classified as in substance real estate investments. We believe that such borrowers typically represent variable interest entities ("VIE" or "VIEs") in accordance with ASC 810 Consolidation. VIEs are required to be consolidated by their primary beneficiary ("PB") which is the enterprise that has both: (i) the power to direct the activities of the VIE that most significantly impacts the entity's economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. We have concluded that we are not the PB of such borrowers, therefore, the loan arrangements were assessed based on among other factors, the amount and timing of expected residual profits, the estimated fair value of the collateral and the significance of the borrower's equity in the project. Based on these assessments, the arrangements have been classified as in substance real estate investments. We expect to fund an additional $36,059,000 during 2021 related to these investments.
9. Credit Concentration
We use consolidated net operating income (“NOI”) as our credit concentration metric. See Note 18 for additional information and reconciliation. The following table summarizes certain information about our credit concentration for the three months ended March 31, 2021, excluding our share of NOI in unconsolidated entities (dollars in thousands):
Concentration by relationship: (1)
Number of PropertiesTotal NOI
Percent of NOI (2)
Sunrise Senior Living (3)
165 $60,933 14%
ProMedica216 53,031 13%
Genesis Healthcare52 26,871 7%
Revera (3)
92 20,865 5%
Avery Healthcare61 20,623 5%
Remaining portfolio912 252,413 56%
Totals1,498 $434,736 100%
(1) Sunrise Senior Living and Revera are in our Seniors Housing Operating segment. Genesis Healthcare and ProMedica are in our Triple-net segment. Avery Healthcare is in both the Triple-net and Seniors Housing Operating segments.
(2) NOI with our top five relationships comprised 36% of total NOI for the year ended December 31, 2020.
(3) Revera owns a controlling interest in Sunrise Senior Living.
During the quarter ended March 31, 2021, we entered into definitive agreements to substantially exit our operating relationship with Genesis Healthcare ("Genesis"). In April 2021, we contributed nine Triple-net properties operated by Genesis into an 80/20 joint venture with ProMedica and such properties were added to the existing master lease with ProMedica. Additionally, we have entered into definitive agreements to sell 35 Genesis properties for $496 million to a joint venture with Aurora Health Network and Peace Capital. These property dispositions and the transfer of operations of these properties is expected to occur in the second and third quarters. Additionally, we currently lease seven properties which we sublease to Genesis. We have entered into an agreement to transition the operations of these properties into a new lease agreement with a regional operator. To effectuate the transition of all 51 properties, we agreed to provide Genesis a lease termination fee of $86 million upon successful transition of all properties, which will be used to immediately repay indebtedness to Welltower. Additionally, upon achievement of certain restructuring milestones, we will reduce Genesis' indebtedness by an additional $170 million in exchange for an equity interest in Genesis. Upon conclusion of the aforementioned loan transactions, Genesis will have $167 million of indebtedness to Welltower, exclusive of additional PIK interest, which will carry a maturity date of January 1, 2024. As of March 31, 2021, our total carrying value of Genesis loans receivable was $139,332,000.
10. Borrowings Under Credit Facilities and Commercial Paper Program 
At March 31, 2021, we had a primary unsecured credit facility with a consortium of 31 banks that includes a $3,000,000,000 unsecured revolving credit facility (none outstanding at March 31, 2021), a $500,000,000 unsecured term credit facility and a $250,000,000 Canadian-denominated unsecured term credit facility. We have an option, through an accordion feature, to upsize the unsecured revolving credit facility and the $500,000,000 unsecured term credit facility by up to an additional $1,000,000,000, in the aggregate, and the $250,000,000 Canadian-denominated unsecured term credit facility by up to an additional $250,000,000. The primary unsecured credit facility also allows us to borrow up to $1,000,000,000 in alternate currencies (none outstanding at March 31, 2021). Borrowings under the unsecured revolving credit facility are subject to interest payable at the applicable margin over LIBOR interest rate. The applicable margin is based on our debt ratings and was 0.825% at March 31, 2021. In addition, we pay a facility fee quarterly to each bank based on the bank’s commitment amount. The facility fee depends on our debt ratings and was 0.15% at March 31, 2021. The term credit facilities mature on July 19, 2023. The revolving credit facility is scheduled to mature on July 19, 2022 and can be extended for two successive terms of six months each at our option.

15

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

In January 2019, we established an unsecured commercial paper program. Under the terms of the program, we may issue unsecured commercial paper notes with maturities that vary, but do not exceed 397 days from the date of issue, up to a maximum aggregate face or principal amount outstanding at any time of $1,000,000,000 (none outstanding at March 31, 2021).
The following information relates to aggregate borrowings under the unsecured revolving credit facility and commercial paper program for the periods presented (dollars in thousands):
Three Months Ended March 31,
20212020
Balance outstanding at quarter end$ $845,000 
Maximum amount outstanding at any month end$ $2,100,000 
Average amount outstanding (total of daily
principal balances divided by days in period)
$ $1,593,816 
Weighted average interest rate (actual interest
expense divided by average borrowings outstanding)
 %2.21 %
 
11. Senior Unsecured Notes and Secured Debt 
We may repurchase, redeem or refinance senior unsecured notes from time to time, taking advantage of favorable market conditions when available. We may purchase senior notes for cash through open market purchases, privately negotiated transactions, a tender offer or, in some cases, through the early redemption of such securities pursuant to their terms. The senior unsecured notes are redeemable at our option, at any time in whole or from time to time in part, at a redemption price equal to the sum of: (i) the principal amount of the notes (or portion of such notes) being redeemed plus accrued and unpaid interest thereon up to the redemption date and (ii) any “make-whole” amount due under the terms of the notes in connection with early redemptions. Redemptions and repurchases of debt, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. At March 31, 2021, the annual principal payments due on these debt obligations were as follows (in thousands):
Senior
Unsecured Notes (1,2)
Secured
Debt (1,3)
Totals
2021$ $438,772 $438,772 
2022 (4)
870,000 463,891 1,333,891 
2023 (5,6)
1,372,602 373,613 1,746,215 
2024 1,350,000 183,982 1,533,982 
20251,250,000 180,595 1,430,595 
Thereafter (7,8,9)
7,436,990 695,319 8,132,309 
Totals$12,279,592 $2,336,172 $14,615,764 
(1) Amounts represent principal amounts due and do not include unamortized premiums/discounts, debt issuance costs, or other fair value adjustments as reflected on the Consolidated Balance Sheet.
(2) Annual interest rates range from 0.81% to 6.50%.
(3) Annual interest rates range from 0.04% to 7.93%. Carrying value of the properties securing the debt totaled $5,330,000,000 at March 31, 2021.
(4) Includes a $860,000,000 unsecured term credit facility. The loan matures on April 1, 2022 and bears interest at LIBOR plus 1.20% (1.31% at March 31, 2021).
(5) Includes a $250,000,000 Canadian-denominated unsecured term credit facility (approximately $198,850,000 based on the Canadian/U.S. Dollar exchange rate on March 31, 2021). The loan matures on July 19, 2023 and bears interest at the Canadian Dealer Offered Rate plus 0.9% (1.31% at March 31, 2021).
(6) Includes a $500,000,000 unsecured term credit facility. The loan matures on July 19, 2023 and bears interest at LIBOR plus 0.9% (1.01% at March 31, 2021).
(7) Includes a $300,000,000 Canadian-denominated 2.95% senior unsecured notes due 2027 (approximately $238,620,000 based on the Canadian/U.S. Dollar exchange rate on March 31, 2021).
(8) Includes a £550,000,000 4.80% senior unsecured notes due 2028 (approximately $758,670,000 based on the Sterling/U.S. Dollar exchange rate in effect on March 31, 2021).
(9) Includes a £500,000,000 4.50% senior unsecured notes due 2034 (approximately $689,700,000 based on the Sterling/U.S. Dollar exchange rate in effect on March 31, 2021).
The following is a summary of our senior unsecured notes principal activity during the periods presented (dollars in thousands):

16

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
 Three Months Ended
 March 31, 2021March 31, 2020
 Weighted Avg.Weighted Avg.
 AmountInterest RateAmountInterest Rate
Beginning balance$11,509,533 3.67%$10,427,562 4.03%
Debt issued750,000 2.80% %
Foreign currency20,059 3.90%(120,689)4.15%
Ending balance$12,279,592 3.62%$10,306,873 3.97%
The following is a summary of our secured debt principal activity for the periods presented (dollars in thousands): 
 Three Months Ended
 March 31, 2021March 31, 2020
 Weighted Avg.Weighted Avg.
 AmountInterest RateAmountInterest Rate
Beginning balance$2,378,073 3.27%$2,993,342 3.63%
Debt issued %44,921 2.58%
Debt extinguished(41,933)7.60%(16,040)4.51%
Principal payments(15,955)3.59%(15,526)3.78%
Foreign currency15,987 2.92%(102,059)3.27%
Ending balance$2,336,172 3.14%$2,904,638 3.63%
On March 25, 2021, we completed the issuance of $750,000,000 senior unsecured notes bearing interest at 2.80% with a maturity date of June 2031. On April 15, 2021 net proceeds were used to redeem $339,128,000 of our 3.75% senior unsecured notes due March 2023 and $334,624,000 of our 3.95% senior unsecured notes due September 2023. We expect to recognize a loss on extinguishment of approximately $51 million in April in conjunction with the transaction.
Our debt agreements contain various covenants, restrictions and events of default. Certain agreements require us to maintain certain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of March 31, 2021, we were in compliance with all of the covenants under our debt agreements. 
12. Derivative Instruments
We are exposed to, among other risks, the impact of changes in foreign currency exchange rates as a result of our non-U.S. investments and interest rate risk related to our capital structure. Our risk management program is designed to manage the exposure and volatility arising from these risks, and utilizes foreign currency forward contracts, cross currency swap contracts, interest rate swaps, interest rate locks and debt issued in foreign currencies to offset a portion of these risks.
Foreign Currency Forward Contracts Designated as Cash Flow Hedges
For instruments that are designated and qualify as a cash flow hedge, the effective portion of the gain or loss on the derivative is deferred as a component of other comprehensive income (“OCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in earnings. 
Cash Flow Hedges of Interest Rate Risk
We enter into interest rate swaps in order to maintain a capital structure containing targeted amounts of fixed and floating-rate debt and manage interest rate risk. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for our fixed-rate payments. These interest rate swap agreements were used to hedge the variable cash flows associated with variable-rate debt.
Periodically, we enter into and designate interest rate locks to partially hedge the risk of changes in interest payments attributable to increases in the benchmark interest rate during the period leading up to the probable issuance of fixed-rate debt. We designate our interest rate locks as cash flow hedges. Gains and losses when we settle our interest rate locks are amortized into income over the life of the related debt, except where a material amount is deemed to be ineffective, which would be immediately reclassified to the Consolidated Statements of Comprehensive Income. Approximately $2,562,000 of losses, which are included in OCI, are expected to be reclassified into earnings in the next 12 months.

17

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Foreign Currency Forward Contracts and Cross Currency Swap Contracts Designated as Net Investment Hedges
We use foreign currency forward and cross currency forward swap contracts to hedge a portion of the net investment in foreign subsidiaries against fluctuations in foreign exchange rates. For instruments that are designated and qualify as net investment hedges, the variability in the foreign currency to U.S. Dollar of the instrument is recorded as a cumulative translation adjustment component of OCI.
Derivative Contracts Undesignated
We use foreign currency exchange contracts to manage existing exposures to foreign currency exchange risk. Gains and losses resulting from the changes in fair value of these instruments are recorded in interest expense on the Consolidated Statements of Comprehensive Income and are substantially offset by net revaluation impacts on foreign currency denominated balance sheet exposures. In addition, we have several interest rate cap contracts related to variable rate secured debt agreements. Gains and losses resulting from the changes in fair values of these instruments are also recorded in interest expense.
The following presents the notional amount of derivatives and other financial instruments as of the dates indicated (in thousands): 
 March 31, 2021December 31, 2020
Derivatives designated as net investment hedges:
Denominated in Canadian Dollars$625,000 $625,000 
Denominated in Pound Sterling£1,340,708 £1,340,708 
Financial instruments designated as net investment hedges:
Denominated in Canadian Dollars$250,000 $250,000 
Denominated in Pound Sterling£1,050,000 £1,050,000 
Interest rate swaps designated as cash flow hedges:
Denominated in U.S Dollars (1)
$25,000 $450,000 
Derivative instruments not designated:
Interest rate caps denominated in U.S. Dollars$26,137 $26,137 
Forward sales contracts denominated in Canadian Dollars$80,000 $80,000 
Forward purchase contracts denominated in Pound Sterling£(32,157)£ 
(1) At March 31, 2021 the maximum maturity date was November 1, 2023.
The following presents the impact of derivative instruments on the Consolidated Statements of Comprehensive Income for the periods presented (in thousands):
Three Months Ended March 31,
DescriptionLocation20212020
Gain (loss) on derivative instruments designated as hedges recognized in incomeInterest expense$6,024 $6,644 
Gain (loss) on derivative instruments not designated as hedges recognized in incomeInterest expense$(719)$(95)
Gain (loss) on derivative and financial instruments designated as hedges recognized in OCIOCI$(20,037)$259,112 
13. Commitments and Contingencies
At March 31, 2021, we had 10 outstanding letter of credit obligations totaling $20,288,000 and expiring between 2021 and 2024. At March 31, 2021, we had outstanding construction in progress of $542,302,000 and were committed to providing additional funds of approximately $715,955,000 to complete construction. Additionally, at March 31, 2021, we had outstanding investments classified as in substance real estate of $365,488,000 and were committed to provide additional funds of $36,059,000 (see Note 8 for additional information). Purchase obligations at March 31, 2021 also include $40,815,000 of contingent purchase obligations to fund capital improvements. Rents due from the tenant are increased to reflect the additional investment in the property.




18

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
14. Stockholders’ Equity 
The following is a summary of our stockholders’ equity capital accounts as of the dates indicated: 
 March 31, 2021December 31, 2020
Preferred Stock:
Authorized shares50,000,000 50,000,000 
Issued shares  
Outstanding shares  
Common Stock, $1.00 par value:
Authorized shares700,000,000 700,000,000 
Issued shares419,306,453 419,124,469 
Outstanding shares417,520,420 417,400,602 
Common Stock In February 2019, we entered into an amended and restated equity distribution agreement whereby we can offer and sell up to $1,500,000,000 aggregate amount of our common stock ("Equity Shelf Program"). The Equity Shelf Program also allows us to enter into forward sale agreements. As of March 31, 2021, we had $499,341,000 of remaining capacity under the Equity Shelf Program, which excludes forward sales agreements outstanding for the sale of 2,214,760 shares with maturity dates in 2022. We expect to physically settle the forward sales for cash proceeds.
On May 1, 2020, our Board of Directors authorized a share repurchase program whereby we may repurchase up to $1 billion of common stock through December 31, 2021 (the "Repurchase Program"). Under this authorization, we are not required to purchase shares but may choose to do so in the open market or through private transactions at times and amounts based on our evaluation of market conditions and other factors. We expect to finance any share repurchases under the Repurchase Program using available cash and may use proceeds from borrowings or debt offerings. We did not repurchase any shares of our common stock during the three months ended March 31, 2021.

The following is a summary of our common stock issuances during the three months ended March 31, 2021 and 2020 (dollars in thousands, except shares and average price amounts): 
 Shares IssuedAverage PriceGross ProceedsNet Proceeds
2020 Dividend reinvestment plan issuances175,129 $84.54 $14,805 $14,805 
2020 Equity shelf program issuances6,799,978 86.48 588,072 576,196 
2020 Stock incentive plans, net of forfeitures158,818 — — 
2020 Totals7,133,925 $602,877 $591,001 
2021 Stock incentive plans, net of forfeitures119,818 — — 
2021 Totals119,818 $ $ 
Dividends The decrease in dividends is attributable to the declaration of a reduced cash dividend beginning with the quarter ending March 31, 2020. The following is a summary of our dividend payments (in thousands, except per share amounts): 
 Three Months Ended
 March 31, 2021March 31, 2020
Per ShareAmountPer ShareAmount
Common stock$0.61 $254,952 $0.87 $356,001 
 Accumulated Other Comprehensive Income The following is a summary of accumulated other comprehensive income (loss) for the periods presented (in thousands):
March 31, 2021December 31, 2020
Foreign currency translation$(581,387)$(621,792)
Derivative and financial instruments designated as hedges453,251 473,288 
Total accumulated other comprehensive income (loss)$(128,136)$(148,504)



19

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

15. Stock Incentive Plans
Our 2016 Long-Term Incentive Plan (“2016 Plan”) authorizes up to 10,000,000 shares of common stock to be issued at the discretion of the Compensation Committee of the Board of Directors. Our non-employee directors, officers and key employees are eligible to participate in the 2016 Plan. The 2016 Plan allows for the issuance of, among other things, stock options, stock appreciation rights, restricted stock, deferred stock units, performance units and dividend equivalent rights. Vesting periods for options, deferred stock units and restricted shares generally range from three to five years. Options expire ten years from the date of grant. Stock-based compensation expense totaled $5,576,000 and $7,083,000 for the three months ended March 31, 2021 and 2020, respectfully.
16. Earnings Per Share
The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share data):
Three Months Ended March 31,
 20212020
Numerator for basic earnings per share - net income (loss) attributable to common stockholders
$71,546 $310,284 
Adjustment for net income (loss) attributable to OP units
(1,353)(1,388)
Numerator for diluted earnings per share
$70,193 $308,896 
Denominator for basic earnings per share - weighted average shares417,241 410,306 
Effect of dilutive securities:
Non-vested restricted shares
421 702 
Redeemable OP units
1,396 1,396 
Employee stock purchase program
21 16 
Dilutive potential common shares1,838 2,114 
Denominator for diluted earnings per share - adjusted weighted average shares
419,079 412,420 
Basic earnings per share$0.17 $0.76 
Diluted earnings per share$0.17 $0.75 
As of March 31, 2021, forward sales agreements outstanding for the sale of 2,214,760 shares of common stock were not included in the computation of diluted earnings per share because such forward sales were anti-dilutive for the period.
17. Disclosure about Fair Value of Financial Instruments 
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. A three-level valuation hierarchy exists for disclosures of fair value measurements based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. A financial instrument's categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Please see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2020 for additional information. The three levels are defined below: 
Level 1 - Quoted prices in active markets for identical assets or liabilities. 
Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value.                                         
Mortgage Loans, Other Real Estate Loans and Non-real Estate Loans Receivable — The fair value of mortgage loans, other real estate loans and non-real estate loans receivable is generally estimated by using Level 2 and Level 3 inputs such as discounting the estimated future cash flows using the current rates at which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities.


20

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Cash and Cash Equivalents and Restricted Cash — The carrying amount approximates fair value. 
Equity Securities — Equity securities are recorded at their fair value based on Level 1 publicly available trading prices. 
Borrowings Under Primary Unsecured Credit Facility and Commercial Paper Program — The carrying amount of the primary unsecured credit facility and commercial paper program approximates fair value because the borrowings are interest rate adjustable. 
Senior Unsecured Notes — The fair value of the senior unsecured notes payable was estimated based on Level 1 publicly available trading prices. The carrying amount of the variable rate senior unsecured notes approximates fair value because they are interest rate adjustable. 
Secured Debt — The fair value of fixed rate secured debt is estimated using Level 2 inputs by discounting the estimated future cash flows using the current rates at which similar loans would be made with similar credit ratings and for the same remaining maturities. The carrying amount of variable rate secured debt approximates fair value because the borrowings are interest rate adjustable. 
Foreign Currency Forward Contracts, Interest Rate Swaps and Cross Currency Swaps — Foreign currency forward contracts, interest rate swaps and cross currency swaps are recorded in other assets or other liabilities on the balance sheet at fair value that is derived from observable market data, including yield curves and foreign exchange rates (all of our derivatives are Level 2).
Redeemable OP Unitholder Interests — Our redeemable OP unitholder interests are recorded on the balance sheet at fair value using Level 2 inputs unless the fair value is below the initial amount in which case the redeemable OP unitholder interests are recorded at the initial amount adjusted for distributions to the unitholders and income or loss attributable to the unitholders. The fair value is measured using the closing price of our common stock, as units may be redeemed at the election of the holder for cash or, at our option, one share of our common stock per unit, subject to adjustment in certain circumstances. 
The carrying amounts and estimated fair values of our financial instruments are as follows (in thousands):
 March 31, 2021December 31, 2020
 Carrying AmountFair ValueCarrying AmountFair Value
Financial assets:
Mortgage loans receivable$331,648 $331,710 $293,752 $297,207 
Other real estate loans receivable156,026 157,310 149,620 152,211 
Equity securities2,702 2,702 4,636 4,636 
Cash and cash equivalents2,131,846 2,131,846 1,545,046 1,545,046 
Restricted cash426,976 426,976 475,997 475,997 
Non-real estate loans receivable242,928260,351 240,269 255,724 
Foreign currency forward contracts, interest rate swaps and cross currency swaps753 753 4,668 4,668 
Financial liabilities:
Senior unsecured notes$12,183,710 $13,377,367 $11,420,790 $13,093,926 
Secured debt2,329,474 2,410,790 2,377,930 2,451,782 
Foreign currency forward contracts, interest rate swaps and cross currency swaps84,985 84,985 118,054 118,054 
Redeemable OP unitholder interests$127,859 $127,859 $116,240 $115,346 
Items Measured at Fair Value on a Recurring Basis 
The market approach is utilized to measure fair value for our financial assets and liabilities reported at fair value on a recurring basis. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The following summarizes items measured at fair value on a recurring basis (in thousands):
 Fair Value Measurements as of March 31, 2021
 TotalLevel 1Level 2Level 3
Equity securities$2,702 $2,702 $ $ 
Foreign currency forward contracts, interest rate swaps and cross currency swaps, net asset (liability) (1)
(84,232) (84,232) 
Totals $(81,530)$2,702 $(84,232)$ 
(1) Please see Note 12 for additional information.
21

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Items Measured at Fair Value on a Nonrecurring Basis 
In addition to items that are measured at fair value on a recurring basis, we also have assets and liabilities in our balance sheet that are measured at fair value on a nonrecurring basis that are not included in the tables above. Assets, liabilities and noncontrolling interests that are measured at fair value on a nonrecurring basis include those acquired or assumed. Asset impairments (if applicable, see Note 5 for impairments of real property and Note 7 for impairments of loans receivable) are also measured at fair value on a nonrecurring basis. We have determined that the fair value measurements included in each of these assets and liabilities rely primarily on company-specific inputs and our assumptions about the use of the assets and settlement of liabilities, as observable inputs are not available. As such, we have determined that each of these fair value measurements generally resides within Level 3 of the fair value hierarchy. We estimate the fair value of real estate and related intangibles using the income approach and unobservable data such as net operating income and estimated capitalization and discount rates. We also consider local and national industry market data including comparable sales, and commonly engage an external real estate appraiser to assist us in our estimation of fair value. We estimate the fair value of assets held for sale based on current sales price expectations or, in the absence of such price expectations, Level 3 inputs described above. We estimate the fair value of loans receivable using projected payoff valuations based on the expected future cash flows and/or the estimated fair value of collateral, net of sales costs, if the repayment of the loan is expected to be provided solely by the collateral. We estimate the fair value of secured debt assumed in asset acquisitions using current interest rates at which similar borrowings could be obtained on the transaction date. 
18. Segment Reporting
We invest in seniors housing and health care real estate. We evaluate our business and make resource allocations on our three operating segments: Seniors Housing Operating, Triple-net and Outpatient Medical. Our Seniors Housing Operating properties include seniors apartments, assisted living, independent living/continuing care retirement communities, independent supportive living communities (Canada), care homes with and without nursing (U.K.) and combinations thereof that are owned and/or operated through RIDEA structures (see Note 19). Our Triple-net properties include the property types described above as well as long-term/post-acute care facilities. Under the Triple-net segment, we invest in seniors housing and health care real estate through acquisition and financing of primarily single tenant properties. Properties acquired are primarily leased under triple-net leases and we are not involved in the management of the property. Our Outpatient Medical properties are typically leased to multiple tenants and generally require a certain level of property management by us.
We evaluate performance based upon consolidated NOI of each segment. We define NOI as total revenues, including tenant reimbursements, less property operating expenses. We believe NOI provides investors relevant and useful information as it measures the operating performance of our properties at the property level on an unleveraged basis. We use NOI to make decisions about resource allocations and to assess the property level performance of our properties.  
Non-segment revenue consists mainly of interest income on certain non-real estate investments and other income. Non-segment assets consist of corporate assets including cash, deferred loan expenses and corporate offices and equipment among others. Non-property specific revenues and expenses are not allocated to individual segments in determining NOI.
The accounting policies of the segments are the same as those described in the summary of significant accounting policies (see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2020). The results of operations for all acquisitions described in Note 3 are included in our consolidated results of operations from the acquisition dates and are components of the appropriate segments. All inter-segment transactions are eliminated.
22

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Summary information for the reportable segments (which excludes unconsolidated entities) is as follows (in thousands): 
Three Months Ended March 31, 2021:Seniors Housing OperatingTriple-netOutpatient MedicalNon-segment / CorporateTotal
Resident fees and services$723,464 $ $ $ $723,464 
Rental income 152,463 150,380  302,843 
Interest income1,119 14,922 3,538  19,579 
Other income1,819 1,097 2,305 955 6,176 
Total revenues726,402 168,482 156,223 955 1,052,062 
Property operating expenses555,968 12,841 46,863 1,654 617,326 
Consolidated net operating income170,434 155,641 109,360 (699)434,736 
Depreciation and amortization132,586 56,667 55,173  244,426 
Interest expense11,418 1,882 4,015 105,827 123,142 
General and administrative expenses   29,926 29,926 
Loss (gain) on derivatives and financial instruments, net 1,934   1,934 
Loss (gain) on extinguishment of debt, net(4,643)   (4,643)
Provision for loan losses251 853 279  1,383 
Impairment of assets4,604 18,964   23,568 
Other expenses3,459 4,983 712 1,840 10,994 
Income (loss) from continuing operations before income taxes and other items22,759 70,358 49,181 (138,292)4,006 
Income tax (expense) benefit   (3,943)(3,943)
Income (loss) from unconsolidated entities5,234 4,907 2,908  13,049 
Gain (loss) on real estate dispositions, net5,195 2,042 51,843  59,080 
Income (loss) from continuing operations33,188 77,307 103,932 (142,235)72,192 
Net income (loss)$33,188 $77,307 $103,932 $(142,235)$72,192 
Total assets$16,032,225 $8,660,043 $6,380,835 $1,919,148 $32,992,251 
Three Months Ended March 31, 2020:Seniors Housing OperatingTriple-netOutpatient MedicalNon-segment / CorporateTotal
Resident fees and services$849,972 $ $ $ $849,972 
Rental income 191,385 198,575  389,960 
Interest income104 14,671 466  15,241 
Other income1,052 1,673 288 416 3,429 
Total revenues851,128 207,729 199,329 416 1,258,602 
Property operating expenses607,871 13,302 60,608  681,781 
Consolidated net operating income243,257 194,427 138,721 416 576,821 
Depreciation and amortization146,774 57,694 70,333  274,801 
Interest expense16,434 2,852 4,808 117,913 142,007 
General and administrative expenses   35,481 35,481 
Loss (gain) on derivatives and financial instruments, net 7,651   7,651 
Provision for loan losses 7,072   7,072 
Impairment of assets3,495 24,332   27,827 
Other expenses2,989 513 

1,007 1,783 6,292 
Income (loss) from continuing operations before income taxes and other items73,565 94,313 62,573 (154,761)75,690 
Income tax (expense) benefit   (5,442)(5,442)
Income (loss) from unconsolidated entities(11,024)5,796 1,536  (3,692)
Gain (loss) on real estate dispositions, net(149)49,637 213,336  262,824 
Income (loss) from continuing operations62,392 149,746 277,445 (160,203)329,380 
Net income (loss)$62,392 $149,746 $277,445 $(160,203)$329,380 


23

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Our portfolio of properties and other investments are located in the United States, the United Kingdom and Canada. Revenues and assets are attributed to the country in which the property is physically located. The following is a summary of geographic information for the periods presented (dollars in thousands): 
 Three Months Ended
 March 31, 2021March 31, 2020
Revenues:
Amount(1)
%Amount%
United States$825,648 78.5 %$1,027,781 81.6 %
United Kingdom118,874 11.3 %117,882 9.4 %
Canada107,540 10.2 %112,939 9.0 %
Total$1,052,062 100.0 %$1,258,602 100.0 %
 As of
 March 31, 2021December 31, 2020
Assets:Amount%Amount%
United States$27,112,760 82.1 %$26,658,659 82.1 %
United Kingdom3,415,851 10.4 %3,352,549 10.3 %
Canada2,463,640 7.5 %2,472,434 7.6 %
Total$32,992,251 100.0 %$32,483,642 100.0 %
(1) The United States, United Kingdom and Canada represent 72%, 14% and 14%, respectively, of our resident fees and services revenue stream for the three months ended March 31, 2021.
19. Income Taxes and Distributions 
We elected to be taxed as a REIT commencing with our first taxable year. To qualify as a REIT for federal income tax purposes, at least 90% of taxable income (excluding 100% of net capital gains) must be distributed to stockholders. REITs that do not distribute a certain amount of taxable income in the current year are also subject to a 4% federal excise tax. The main differences between undistributed net income for federal income tax purposes and financial statement purposes are the recognition of straight-line rent for reporting purposes, basis differences in acquisitions, recording of impairments, differing useful lives and depreciation and amortization methods for real property and the provision for loan losses for reporting purposes versus bad debt expense for tax purposes. 
Under the provisions of the REIT Investment Diversification and Empowerment Act of 2007 (“RIDEA”), for taxable years beginning after July 30, 2008, a REIT may lease “qualified health care properties” on an arm’s-length basis to a taxable REIT subsidiary (“TRS”) if the property is operated on behalf of such TRS by a person who qualifies as an “eligible independent contractor”. Generally, the rent received from the TRS will meet the related party rent exception and will be treated as “rents from real property”. A “qualified health care property” includes real property and any personal property that is, or is necessary or incidental to the use of, a hospital, nursing facility, assisted living facility, congregate care facility, qualified continuing care facility, or other licensed facility which extends medical or nursing or ancillary services to patients. We have entered into various joint ventures that were structured under RIDEA. Resident level rents and related operating expenses for these facilities are reported in the unaudited consolidated financial statements and are subject to federal and state income taxes as the operations of such facilities are included in TRS entities. Certain net operating loss carryforwards could be utilized to offset taxable income in future years. 
Income taxes reflected in the financial statements primarily represents U.S. federal, state and local income taxes as well as non-U.S. income based or withholding taxes on certain investments located in jurisdictions outside the U.S. The provision for income taxes for the three months ended March 31, 2021 and 2020, was primarily due to operating income or losses, offset by certain discrete items at our TRS entities. In 2014, we established certain wholly-owned direct and indirect subsidiaries in Luxembourg and Jersey and transferred interests in certain foreign investments into this holding company structure. The structure includes a property holding company that is tax resident in the United Kingdom. No material adverse current tax consequences in Luxembourg, Jersey or the United Kingdom resulted from the creation of this holding company structure and most of the subsidiary entities in the structure are treated as disregarded entities of the company for U.S. federal income tax purposes. Subsequent to 2014 we transferred certain subsidiaries to the United Kingdom, while some wholly-owned direct and indirect subsidiaries remain in Luxembourg and Jersey. The company reflects current and deferred tax liabilities for any such withholding taxes incurred from this holding company structure in its consolidated financial statements. Generally, given current statutes of limitations, we are subject to audit by the foreign, federal, state and local taxing authorities under applicable local laws.
24

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
The CARES Act, among its economic stimulus provisions, includes a number of tax provisions relating to refundable payroll tax credits, deferment of employer side social security payments, net operating loss carrybacks, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to tax depreciation methods for qualified improvement property. Certain of these provisions may impact the provision for taxes in our consolidated financial statements, including in particular the provision allowing for the carryback of net operating losses which would be applicable to our TRSs. We have made a reasonable estimate of the tax impact to us of the CARES Act in our consolidated financial statements, and while we do not believe that there will be further material impacts to the consolidated financial statements related to the CARES Act tax provisions, we will continue to evaluate the impact of the CARES Act and any guidance provided by the U.S. Treasury and the IRS on our consolidated financial statements. It is possible our estimates could differ materially from the actual tax impact to us of the CARES Act.
20. Variable Interest Entities 
We have entered into joint ventures to own certain seniors housing and outpatient medical assets which are deemed to be VIEs. We have concluded that we are the primary beneficiary of these VIEs based on a combination of operational control of the joint venture and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures. Except for capital contributions associated with the initial joint venture formations, the joint ventures have been and are expected to be funded from the ongoing operations of the underlying properties. Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs in the aggregate (in thousands):
March 31, 2021December 31, 2020
Assets:
Net real estate investments$451,975 $454,333 
Cash and cash equivalents13,760 15,547 
Receivables and other assets12,669 11,171 
Total assets (1)
$478,404 $481,051 
Liabilities and equity:
Secured debt$165,225 $165,671 
Lease liabilities1,325 1,325 
Accrued expenses and other liabilities16,860 14,997 
Total equity294,994 299,058 
Total liabilities and equity$478,404 $481,051 
(1) Note that assets of the consolidated VIEs can only be used to settle obligations relating to such VIEs. Liabilities of the consolidated VIEs represent claims against the specific assets of the VIEs.
25

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
EXECUTIVE SUMMARY
   
Company Overview
Business Strategy
Key Transactions
 Key Performance Indicators, Trends and Uncertainties
Corporate Governance
 LIQUIDITY AND CAPITAL RESOURCES
   
Sources and Uses of Cash
Off-Balance Sheet Arrangements
Contractual Obligations
Capital Structure
   
 RESULTS OF OPERATIONS
   
Summary
Seniors Housing Operating
Triple-net
Outpatient Medical
Non-Segment/Corporate
   
 OTHER
   
 Non-GAAP Financial Measures
 Critical Accounting Policies
 Cautionary Statement Regarding Forward-Looking Statements
26

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis is based primarily on the unaudited consolidated financial statements of Welltower Inc. for the periods presented and should be read together with the notes thereto contained in this Quarterly Report on Form 10-Q. Other important factors are identified in our Annual Report on Form 10-K for the year ended December 31, 2020, including factors identified under the headings “Business,” “Risk Factors,” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations". References herein to “we,” “us,” “our,” or the “Company” refer to Welltower Inc. and its subsidiaries unless specifically noted otherwise.
Executive Summary
Company Overview
Welltower Inc. (NYSE:WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience. Welltower™, a real estate investment trust (“REIT”), owns interests in properties concentrated in major, high-growth markets in the United States (U.S.), Canada and the United Kingdom (U.K.), consisting of seniors housing and post-acute communities and outpatient medical properties.
The following table summarizes our consolidated portfolio for the three months ended March 31, 2021 (dollars in thousands):
  Percentage ofNumber of
Type of Property
NOI (1)
NOIProperties
Seniors Housing Operating$170,434 39.2 %559 
Triple-net155,641 35.7 %649 
Outpatient Medical109,360 25.1 %290 
Totals$435,435 100.0 %1,498 
(1) Represents consolidated NOI and excludes our share of investments in unconsolidated entities. Entities in which we have a joint venture with a minority partner are shown at 100% of the joint venture amount. See Non-GAAP Financial Measures for additional information and reconciliation.
The COVID-19 pandemic has had and may continue to have material and adverse effects on our financial condition, results of operations and cash flows in the future. The extent to which the COVID-19 pandemic impacts our operations and those of our operators and tenants will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the scope, severity and duration of the pandemic, the effectiveness of vaccines, the actions taken to contain the pandemic or mitigate its impact and the direct and indirect economic effects of the pandemic and containment measures, among others.
Our Seniors Housing Operating revenues are dependent on occupancy. Spot occupancy has continued to decline since the beginning of the pandemic, dropping to 73.6% as of March 31, 2021 compared to 75.9% as of December 31, 2020. Approximately 99% of communities are currently accepting new residents, resulting in an acceleration in move-in activity and an increase in occupancy of approximately 60 basis points from a pandemic-low on March 12, 2021 to 73.8% on April 23, 2021. Additionally, rapid distribution and a high acceptance rate of COVID-19 vaccinations by residents within assisted living and memory care facilities in the U.S. and U.K. has resulted in a significant decrease in total resident case counts since mid-January 2021 across the portfolio.
We have incurred increased operational costs as a result of the introduction of public health measures and other regulations affecting our properties, as well as additional health and safety measures adopted by us and our operators related to the COVID-19 pandemic, including increases in labor, personal protective equipment and sanitation. We expect total Seniors Housing Operating expenses to remain elevated during the pandemic and potentially beyond as these additional health and safety measures become standard practice.
Our Triple-net operators are experiencing similar occupancy declines and operating costs as described above with respect to our Seniors Housing Operating properties. However, long-term/post-acute care facilities are generally experiencing a higher degree of occupancy declines. These factors may continue to impact the ability of our Triple-net operators to make contractual rent payments to us in the future. Many of our Triple-net operators received funds under the Coronavirus Aid Relief, and Economic Security Act (“CARES Act”) Paycheck Protection Program. In addition, operators of long-term/post-acute care facilities have generally received funds from Phase 1 of the Provider Relief Fund and operators of assisted living facilities have generally received funds from Phase 2 and Phase 3 of the Provider Relief Fund.

27

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
During the early stages of the pandemic in 2020, our Outpatient Medical tenants experienced temporary medical practice closures or decreases in revenue due to government-imposed restrictions on elective medical procedures, stay at home orders or decisions by patients to delay treatments. These factors caused operators or tenants, in certain circumstances, to seek modifications of rent obligations. We evaluated each request on a case-by-case basis to determine if a form of rent relief was warranted following an examination of the tenant’s financial health, rent coverage, current operating situation and other factors. Virtually all deferred rent has been repaid as of March 31, 2021.
During the first quarter, we collected approximately 96% of rent due from operators under Triple-net lease agreements (primarily seniors housing and post-acute care facilities). No significant rent deferrals or rent concessions have been made. In the Outpatient Medical segment we collected 99% of rent due in the first quarter, with uncollected amounts primarily attributable to local jurisdictions with COVID-19 related ordinances providing temporary rent relief to tenants. For both our Triple-net operators and Outpatient Medical tenants, we evaluate leases individually and recognize rent on a cash basis if collectibility of substantially all contractual rent payments is not probable. To the extent the prolonged impact of the COVID-19 pandemic causes operators or tenants to seek further modifications of their lease agreements, we may recognize reductions in revenue and increases in uncollectible receivables.
Business Strategy
Our primary objectives are to protect stockholder capital and enhance stockholder value. We seek to pay consistent cash dividends to stockholders and create opportunities to increase dividend payments to stockholders as a result of annual increases in NOI and portfolio growth. To meet these objectives, we invest across the full spectrum of seniors housing and health care real estate and diversify our investment portfolio by property type, relationship and geographic location.
Substantially all of our revenues are derived from operating lease rentals, resident fees and services and interest earned on outstanding loans receivable. These items represent our primary sources of liquidity to fund distributions and depend upon the continued ability of our obligors to make contractual rent and interest payments to us and the profitability of our operating properties. To the extent that our obligors/partners experience operating difficulties and become unable to generate sufficient cash to make payments or operating distributions to us, there could be a material adverse impact on our consolidated results of operations, liquidity and/or financial condition. To mitigate this risk, we monitor our investments through a variety of methods determined by the type of property. Our asset management process for seniors housing properties generally includes review of monthly financial statements and other operating data for each property, review of obligor/partner creditworthiness, property inspections and review of covenant compliance relating to licensure, real estate taxes, letters of credit and other collateral. Our internal property management division manages and monitors the outpatient medical portfolio with a comprehensive process including review of tenant relations, lease expirations, the mix of health service providers, hospital/health system relationships, property performance, capital improvement needs and market conditions among other things. We evaluate the operating environment in each property’s market to determine the likely trend in operating performance of the facility. When we identify unacceptable trends, we seek to mitigate, eliminate or transfer the risk. Through these efforts, we generally aim to intervene at an early stage to address any negative trends, and in so doing, support both the collectability of revenue and the value of our investment.
In addition to our asset management and research efforts, we also aim to structure our relevant investments to mitigate payment risk. Operating leases and loans are normally credit enhanced by guarantees and/or letters of credit. In addition, operating leases are typically structured as master leases and loans are generally cross-defaulted and cross-collateralized with other real estate loans, operating leases or agreements between us and the obligor and its affiliates.
For the three months ended March 31, 2021, resident fees and services and rental income represented 69% and 29%, respectively, of total revenues. Substantially all of our operating leases are designed with escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectability assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period. Our yield on loans receivable depends upon a number of factors, including the stated interest rate, the average principal amount outstanding during the term of the loan and any interest rate adjustments.
Our primary sources of cash include resident fees and services, rent and interest receipts, borrowings under our unsecured revolving credit facility and commercial paper program, public issuances of debt and equity securities, proceeds from investment dispositions and principal payments on loans receivable. Our primary uses of cash include dividend distributions, debt service payments (including principal and interest), real property investments (including acquisitions, capital expenditures, construction advances and transaction costs), loan advances, property operating expenses and general and administrative expenses. Depending upon the availability and cost of external capital, we believe our liquidity is sufficient to fund these uses of cash.


28

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
We also continuously evaluate opportunities to finance future investments. New investments are generally funded from temporary borrowings under our unsecured revolving credit facility and commercial paper program, internally generated cash and the proceeds from investment dispositions. Our investments generate cash from NOI and principal payments on loans receivable. Permanent financing for future investments, which replaces funds drawn under our unsecured revolving credit facility and commercial paper program, has historically been provided through a combination of the issuance of public debt and equity securities and the incurrence or assumption of secured debt.
Depending upon market conditions, we believe that new investments will be available in the future with spreads over our cost of capital that will generate appropriate returns to our stockholders. It is also likely that investment dispositions may occur in the future. To the extent that investment dispositions exceed new investments, our revenues and cash flows from operations could be adversely affected. We expect to reinvest the proceeds from any investment dispositions in new investments. To the extent that new investment requirements exceed our available cash on-hand, we expect to borrow under our unsecured revolving credit facility and commercial paper program. At March 31, 2021, we had $2,131,846,000 of cash and cash equivalents, $426,976,000 of restricted cash and $3,000,000,000 of available borrowing capacity under our unsecured revolving credit facility.
Key Transactions
Capital The following summarizes key capital transaction that occurred during the three months ended March 31, 2021 and subsequent events:
During the three months ended March 31, 2021, we extinguished $41,933,000 of secured debt at a blended average interest rate of 7.60%.
During the three months ended March 31, 2021, we sold 2,214,760 shares of common stock under our ATM program via forward sale agreements, generating future expected gross proceeds of approximately $160,375,000.
On March 25, 2021, we completed the issuance of $750,000,000 senior unsecured notes bearing interest at 2.80% with a maturity date of June 2031. On April 15, 2021, net proceeds were used to redeem $339,128,000 of our 3.75% senior unsecured notes due March 2023 and $334,624,000 of our 3.95% senior unsecured notes due September 2023. We expect to recognize a loss on extinguishment of approximately $51 million in April in conjunction with the transaction.
Investments The following summarizes our property acquisitions and joint venture investments completed during the three months ended March 31, 2021 (dollars in thousands): 
 Properties
Investment Amount (1)
Capitalization Rates (2)
Book Amount (3)
Seniors Housing Operating$5,000 9.6 %$5,070 
Triple-net11 190,416 6.1 %194,516 
Outpatient Medical13,997 5.9 %14,282 
Totals13 $209,413 6.2 %$213,868 
(1) Represents stated pro rata purchase price including cash and any assumed debt but excludes fair value adjustments pursuant to U.S. GAAP.
(2) Represents annualized contractual or projected net operating income to be received in cash divided by investment amounts.
(3) Represents amounts recorded in net real estate investments including fair value adjustments pursuant to U.S. GAAP. See Note 3 to our unaudited consolidated financial statements for additional information.
Dispositions The following summarizes property dispositions completed during the three months ended March 31, 2021 (dollars in thousands): 
 Properties
Proceeds (1)
Capitalization Rates (2)
Book Amount (3)
Seniors Housing Operating4$57,501 6.1 %$74,326 
Outpatient Medical8158,878 5.2 %137,890 
Totals12 $216,379 5.5 %$212,216 
(1) Represents pro rata proceeds received upon disposition including any seller financing.
(2) Represents annualized contractual income that was being received in cash at date of disposition divided by disposition proceeds.
(3) Represents carrying value of net real estate assets at time of disposition. See Note 5 to our unaudited consolidated financial statements for additional information.
Dividends Our Board of Directors declared a cash dividend for the quarter ended March 31, 2021 of $0.61 per share. On May 20, 2021, we will pay our 200th consecutive quarterly cash dividend to stockholders of record on May 11, 2021.
29

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Key Performance Indicators, Trends and Uncertainties
We utilize several key performance indicators to evaluate the various aspects of our business. These indicators are discussed below and relate to operating performance, credit strength and concentration risk. Management uses these key performance indicators to facilitate internal and external comparisons to our historical operating results, in making operating decisions and for budget planning purposes.
Operating Performance We believe that net income and net income attributable to common stockholders (“NICS”) per the Consolidated Statements of Comprehensive Income are the most appropriate earnings measures. Other useful supplemental measures of our operating performance include funds from operations attributable to common stockholders (“FFO”) and consolidated net operating income (“NOI”); however, these supplemental measures are not defined by U.S. generally accepted accounting principles (“U.S. GAAP”). Please refer to the section entitled “Non-GAAP Financial Measures” for further discussion and reconciliations. These earnings measures are widely used by investors and analysts in the valuation, comparison and investment recommendations of companies. The following table reflects the recent historical trends of our operating performance measures for the periods presented (in thousands):
 Three Months Ended
 March 31,December 31,September 30,June 30,March 31,
 20212020202020202020
Net income (loss)$72,192 $155,278 $394,978 $159,216 $329,380 
NICS71,546 163,729 325,585 179,246 310,284 
FFO287,167 225,827 185,014 335,597 356,124 
NOI434,736 501,455 402,157 527,711 576,821 
Credit Strength We measure our credit strength both in terms of leverage ratios and coverage ratios. The leverage ratios indicate how much of our balance sheet capitalization is related to long-term debt, net of cash and Internal Revenue Code Section 1031 deposits. The coverage ratios indicate our ability to service interest and fixed charges (interest and secured debt principal amortization). We expect to maintain capitalization ratios and coverage ratios sufficient to maintain a capital structure consistent with our current profile. The coverage ratios are based on earnings before interest, taxes, depreciation and amortization (“EBITDA”). Please refer to the section entitled “Non-GAAP Financial Measures” for further discussion and reconciliation of these measures. Leverage ratios and coverage ratios are widely used by investors, analysts and rating agencies in the valuation, comparison, investment recommendations and rating of companies. The following table reflects the recent historical trends for our credit strength measures for the periods presented: 
 Three Months Ended
 March 31,December 31,September 30,June 30,March 31,
 20212020202020202020
Net debt to book capitalization ratio42%41%41%43%44%
Net debt to undepreciated book capitalization ratio34%34%34%35%37%
Net debt to market capitalization ratio28%30%33%36%40%
Interest coverage ratio3.56x4.20x6.23x4.29x5.42x
Fixed charge coverage ratio3.16x3.72x5.52x3.84x4.88x
Concentration Risk We evaluate our concentration risk in terms of NOI by property mix, relationship mix and geographic mix. Concentration risk is a valuable measure in understanding what portion of our NOI could be at risk if certain sectors were to experience downturns. Property mix measures the portion of our NOI that relates to our various property types. Relationship mix measures the portion of our NOI that relates to our current top five relationships. Geographic mix measures the portion of our NOI that relates to our current top five states (or international equivalents). The following table reflects our recent historical trends of concentration risk by NOI for the periods indicated below: 
30

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
 Three Months Ended
 March 31,December 31,September 30,June 30,March 31,
 20212020202020202020
Property mix:(1)
   
Seniors Housing Operating39%32%43%34%42%
Triple-net36%45%27%42%34%
Outpatient Medical25%23%30%24%24%
Relationship mix: (1)
Sunrise Senior Living (2)
14%12%15%10%14%
ProMedica12%11%13%10%9%
Genesis Healthcare (3)
6%6%(16)%6%5%
Revera (2)
5%4%6%5%6%
Avery Healthcare5%4%5%3%3%
Remaining relationships58%63%77%66%63%
Geographic mix:(1)
California15%12%17%14%15%
United Kingdom10%11%12%8%9%
New Jersey(3)
7%7%(5)%7%8%
Texas7%10%12%10%7%
Canada7%5%8%6%7%
Remaining geographic areas54%55%56%55%54%
(1) Excludes our share of investments in unconsolidated entities and non-segment/corporate NOI. Entities in which we have a joint venture with a minority partner are shown at 100% of the joint venture amount.
(2) Revera owns a controlling interest in Sunrise Senior Living.
(3) During the three months ended September 30, 2020, we reserved for straight-line rent receivable balances of $91,025,000 relating to Genesis Healthcare.
Lease Expirations The following table sets forth information regarding lease expirations for certain portions of our portfolio as of March 31, 2021 (dollars in thousands):
 
Expiration Year (1)
 2021202220232024202520262027202820292030Thereafter
Triple-net:          
Properties67 10 28 66 18 15 14 23 385 
Base rent (2)
$— $2,913 $2,482 $11,431 $6,147 $75,872 $32,044 $16,797 $31,393 $42,135 $342,413 
% of base rent— %0.5 %0.4 %2.0 %1.1 %13.5 %5.7 %3.0 %5.6 %7.5 %60.7 %
Units/beds8,858 862 1,419 777 1,759 5,032 2,350 1,633 1,214 2,439 38,128 
% of Units/beds13.7 %1.3 %2.2 %1.2 %2.7 %7.8 %3.6 %2.5 %1.9 %3.8 %59.3 %
Outpatient Medical:          
Square feet1,099,300 1,588,578 1,749,388 1,944,154 1,025,052 1,212,424 993,193 897,601 718,767 1,391,512 3,848,566 
Base rent (2)
$33,421 $47,751 $49,075 $59,119 $28,696 $32,311 $25,537 $23,587 $20,824 $34,873 $83,241 
% of base rent7.6 %10.9 %11.2 %13.5 %6.5 %7.4 %5.8 %5.4 %4.7 %8.0 %19.0 %
Leases280 335 362 308 213 203 129 113 71 90 144 
% of Leases12.5 %14.9 %16.1 %13.7 %9.5 %9.0 %5.7 %5.0 %3.2 %4.0 %6.4 %
(1) Excludes investments in unconsolidated entities, developments, land parcels, loans receivable and sub-leases. Investments classified as held for sale are included in the current year.
(2) The most recent monthly cash base rent annualized. Base rent does not include tenant recoveries or amortization of above and below market lease intangibles or other non-cash income.
We evaluate our key performance indicators in conjunction with current expectations to determine if historical trends are indicative of future results. Our expected results may not be achieved and actual results may differ materially from our expectations. Factors that may cause actual results to differ from expected results are described in more detail in “Cautionary Statement Regarding Forward-Looking Statements” and other sections of this Quarterly Report on Form 10-Q. Management regularly monitors economic and other factors to develop strategic and tactical plans designed to improve performance and maximize our competitive position. Our ability to achieve our financial objectives is dependent upon our ability to effectively execute these plans and to appropriately respond to emerging economic and company-specific trends. Please refer to our Annual Report on Form 10-K for the year ended December 31, 2020, under the headings “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations”.
31

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Corporate Governance
Maintaining investor confidence and trust is important in today’s business environment. Our Board of Directors and management are strongly committed to policies and procedures that reflect the highest level of ethical business practices. Our corporate governance guidelines provide the framework for our business operations and emphasize our commitment to increase stockholder value while meeting all applicable legal requirements. These guidelines meet the listing standards adopted by the New York Stock Exchange and are available on the Internet at www.welltower.com/investors/governance. The information on our website is not incorporated by reference in this Quarterly Report on Form 10-Q, and our web address is included as an inactive textual reference only.
Liquidity and Capital Resources
Sources and Uses of Cash
Our primary sources of cash include resident fees and services, rent and interest receipts, borrowings under our unsecured revolving credit facility and commercial paper program, public issuances of debt and equity securities, proceeds from investment dispositions and principal payments on loans receivable. Our primary uses of cash include dividend distributions, debt service payments (including principal and interest), real property investments (including acquisitions, capital expenditures, construction advances and transaction costs), loan advances, property operating expenses and general and administrative expenses. These sources and uses of cash are reflected in our Consolidated Statements of Cash Flows and are discussed in further detail below. The following is a summary of our sources and uses of cash flows for the periods presented (dollars in thousands):
 Three Months EndedChange
March 31, 2021March 31, 2020$%
Cash, cash equivalents and restricted cash at beginning of period$2,021,043 $385,766 $1,635,277 424 %
Cash provided from (used in) operating activities303,658 411,857 (108,199)(26)%
Cash provided from (used in) investing activities(139,140)149,748 (288,888)(193)%
Cash provided from (used in) financing activities371,903 (544,295)916,198 168 %
Effect of foreign currency translation1,358 (10,010)11,368 114 %
Cash, cash equivalents and restricted cash at end of period$2,558,822 $393,066 $2,165,756 551 %
Operating Activities The changes in net cash provided from operating activities are primarily attributable to declines in revenue as a result of decreased occupancy at our Seniors Housing Operating properties, straight-line receivable reserves related to Triple-net leases during the three months ended March 31, 2021 and dispositions. Please see “Results of Operations” for discussion of net income fluctuations. For the three months ended March 31, 2021 and 2020, cash flows provided from operations exceeded cash distributions to stockholders. 
Investing Activities The changes in net cash provided from/used in investing activities are primarily attributable to net changes in real property investments and dispositions, loans receivable and investments in unconsolidated entities, which are summarized above in “Key Transactions” and Notes 3 and 5 of our unaudited consolidated financial statements. The following is a summary of cash used in non-acquisition capital improvement activities for the periods presented (dollars in thousands): 
 Three Months EndedChange
 March 31, 2021March 31, 2020$
New development$73,605 $48,775 $24,830 
Recurring capital expenditures, tenant improvements and lease commissions10,754 22,566 (11,812)
Renovations, redevelopments and other capital improvements18,026 46,816 (28,790)
Total$102,385 $118,157 $(15,772)
The change in new development is primarily due to the number and size of construction projects on-going during the relevant periods. Renovations, redevelopments and other capital improvements include expenditures to maximize property value, increase net operating income, maintain a market-competitive position and/or achieve property stabilization. 
Financing Activities The changes in net cash provided from/used in financing activities are primarily attributable to changes related to our long-term debt arrangements, the issuances of common stock and dividend payments which are summarized above in "Key Transactions". Please refer to Notes 10, 11 and 14 of our unaudited consolidated financial statements for additional information.
32

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
On March 25, 2021, we completed the issuance of $750,000,000 senior unsecured notes with a maturity date of June 2031. On April 15, 2021, net proceeds were used to redeem the remaining $339,128,000 of our 3.75% senior unsecured notes due 2023 and $334,624,000 of our 3.95% senior unsecured notes due 2023. As of March 31, 2021, we have total near-term available liquidity of approximately $5.1 billion. However, we are unable to accurately predict the full impact that the pandemic will have on our results from operations, financial condition, liquidity and cash flows due to numerous factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2020, including factors identified under the heading “Risk Factors".
Off-Balance Sheet Arrangements 
At March 31, 2021, we had investments in unconsolidated entities with our ownership generally ranging from 10% to 65%. We use financial derivative instruments to hedge interest rate and foreign currency exchange rate exposure. At March 31, 2021, we had 10 outstanding letter of credit obligations. Please see Notes 8, 12 and 13 to our unaudited consolidated financial statements for additional information.
Contractual Obligations
The following table summarizes our payment requirements under contractual obligations as of March 31, 2021 (in thousands):
 Payments Due by Period
Contractual ObligationsTotal20212022-20232024-2025Thereafter
Senior unsecured notes and term credit facilities: (1)
U.S. Dollar senior unsecured notes$9,023,752 $— $673,752 $2,600,000 $5,750,000 
Canadian Dollar senior unsecured notes (2)
238,620 — — — 238,620 
Pounds Sterling senior unsecured notes (2)
1,448,370 — — — 1,448,370 
U.S. Dollar term credit facility1,370,000 — 1,370,000 — — 
Canadian Dollar term credit facility (2)
198,850 — 198,850 — — 
Secured debt: (1,2)
Consolidated2,336,172 438,772 837,504 364,577 695,319 
Unconsolidated1,139,839 16,407 238,886 608,952 275,594 
Contractual interest obligations: (3)
Senior unsecured notes and term loans (2)
3,977,707 320,376 862,041 694,592 2,100,698 
Consolidated secured debt (2)
296,984 52,586 97,575 58,678 88,145 
Unconsolidated secured debt (2)
204,961 28,292 70,570 45,104 60,995 
Financing lease liabilities (4)
193,288 6,551 77,850 2,864 106,023 
Operating lease liabilities (4)
981,936 14,985 37,538 33,341 896,072 
Purchase obligations (5)
792,829 363,539 372,211 49,804 7,275 
Total contractual obligations$22,203,308 $1,241,508 $4,836,777 $4,457,912 $11,667,111 
(1) Amounts represent principal amounts due and do not reflect unamortized premiums/discounts or other fair value adjustments as reflected on the balance sheet.
(2) Based on foreign currency exchange rates in effect as of balance sheet date.
(3) Based on variable interest rates in effect as of balance sheet date.
(4) See Note 6 to our unaudited consolidated financial statements for additional information.
(5) See Note 13 to our unaudited consolidated financial statements for additional information.
Capital Structure
Please refer to “Credit Strength” above for a discussion of our leverage and coverage ratio trends. Our debt agreements contain various covenants, restrictions and events of default. Certain agreements require us to maintain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of March 31, 2021, we were in compliance with all covenants under our primary unsecured credit facilities and senior note agreements. None of our debt agreements contain provisions for acceleration which could be triggered by our debt ratings. However, under our primary unsecured credit facility, the ratings on our senior unsecured notes are used to determine the fees and interest charged. We plan to manage the company to maintain compliance with our debt covenants and with a capital structure consistent with our current profile. Any downgrades in terms of ratings or outlook by any or all of the rating agencies could have a material adverse impact on our cost and availability of capital, which could have a material adverse impact on our consolidated results of operations, liquidity and/or financial condition.


33

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
On May 17, 2018, we filed with the Securities and Exchange Commission (1) an open-ended automatic or “universal” shelf registration statement covering an indeterminate amount of future offerings of debt securities, common stock, preferred stock, depositary shares, warrants and units and (2) a registration statement in connection with our enhanced dividend reinvestment plan (“DRIP”) under which we may issue up to 15,000,000 shares of common stock. As of April 23, 2021, 2,541,750 shares of common stock remained available for issuance under the DRIP registration statement. On February 25, 2019, we entered into separate amended and restated equity distribution agreements with each of Barclays Capital Inc., Citigroup Global Markets Inc., Credit Agricole Securities (USA) Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc., RBC Capital Markets, LLC, UBS Securities LLC and Wells Fargo Securities, LLC relating to the offer and sale from time to time of up to $1,500,000,000 aggregate amount of our common stock (“Equity Shelf Program”). The Equity Shelf Program also allows us to enter into forward sale agreements. As of April 23, 2021, we had $499,341,000 of remaining capacity under the Equity Shelf Program, which excludes forward sales agreements outstanding for the sale of 3,704,787 shares or approximately $272,059,000 with maturity dates in 2022. We expect to physically settle the forward sales for cash proceeds. Depending upon market conditions, we anticipate issuing securities under our registration statements to invest in additional properties and to repay borrowings under our unsecured revolving credit facility and commercial paper program.
Results of Operations
Summary
Our primary sources of revenue include resident fees and services, rent and interest income. Our primary expenses include property operating expenses, depreciation and amortization, interest expense, general and administrative expenses and other expenses. We evaluate our business and make resource allocations on our three business segments: Seniors Housing Operating, Triple-net and Outpatient Medical. The primary performance measures for our properties are NOI and same store NOI ("SSNOI"), and other supplemental measures include FFO and EBITDA, which are further discussed below. Please see Non-GAAP Financial Measures for additional information and reconciliations. The following is a summary of our results of operations (dollars in thousands, except per share amounts):
 Three Months EndedChange
 March 31,March 31,  
 20212020Amount%
Net income$72,192 $329,380 $(257,188)(78)%
NICS71,546 310,284 (238,738)(77)%
FFO287,167 356,124 (68,957)(19)%
EBITDA443,703 751,630 (307,927)(41)%
NOI434,736 576,821 (142,085)(25)%
SSNOI395,076 461,491 (66,415)(14)%
Per share data (fully diluted):    
NICS$0.17 $0.75 $(0.58)(77)%
FFO$0.69 $0.86 $(0.17)(20)%
Interest coverage ratio3.56 x5.42 x(1.86)x(34)%
Fixed charge coverage ratio3.16 x4.88 x(1.72)x(35)%
Seniors Housing Operating
The following is a summary of our SSNOI at Welltower's Share for the Seniors Housing Operating segment (dollars in thousands):
QTD Pool
 Three Months EndedChange
 March 31, 2021March 31, 2020$%
SSNOI (1)
$156,791 $219,756 $(62,965)(28.7)%
(1) For the three months ended March 31, 2021 and 2020, amounts relate to 526 same store properties, respectively. Please see Non-GAAP Financial Measures for additional information and reconciliations.
The following is a summary of our results of operations for the Seniors Housing Operating segment (dollars in thousands):
34

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
 Three Months EndedChange
 March 31,March 31,  
 20212020$%
Revenues:    
Resident fees and services
$723,464 $849,972 $(126,508)(15)%
Interest income
1,119 104 1,015 976 %
Other income
1,819 1,052 767 73 %
Total revenues
726,402 851,128 (124,726)(15)%
Property operating expenses555,968 607,871 (51,903)(9)%
NOI (1)
170,434 243,257 (72,823)(30)%
Other expenses:   
Depreciation and amortization
132,586 146,774 (14,188)(10)%
Interest expense
11,418 16,434 (5,016)(31)%
Loss (gain) on extinguishment of debt, net
(4,643)— (4,643)n/a
Provision for loan losses251 — 251 n/a
Impairment of assets
4,604 3,495 1,109 32 %
Other expenses
3,459 2,989 470 16 %
147,675 169,692 (22,017)(13)%
Income (loss) from continuing operations before income taxes and other items22,759 73,565 (50,806)(69)%
Income (loss) from unconsolidated entities5,234 (11,024)16,258 147 %
Gain (loss) on real estate dispositions, net5,195 (149)5,344 n/a
Income from continuing operations33,188 62,392 (29,204)(47)%
Net income (loss)33,188 62,392 (29,204)(47)%
Less: Net income (loss) attributable to noncontrolling interests(4,924)(1,932)(2,992)n/a
Net income (loss) attributable to common stockholders$38,112 $64,324 $(26,212)(41)%
(1) See Non-GAAP Financial Measures below.
Decreases in resident fees and services and property operating expenses are primarily a result of decreases in occupancy across the portfolio due to the COVID-19 pandemic and property dispositions. Spot occupancy has continued to decline since the beginning of the pandemic, dropping to 73.6% as of March 31, 2021 compared to 75.9% as of December 31, 2020. Spot occupancy rates from the start of the pandemic through March 31, 2021 are as follows:
February 2020December 2020January 2021February 2021March 2021
Spot occupancy (1)
85.4 %75.9 %74.4 %73.6 %73.6 %
Sequential occupancy change(1.5)%(0.8)%— %
(1) Spot occupancy represents approximate month end occupancy at our share for properties in operation as of February 29, 2020, including unconsolidated properties but excluding acquisitions, dispositions and development conversions since this date.
Property-level operating expenses associated with the COVID-19 pandemic relating to our Seniors Housing Operating portfolio, net of reimbursements including Provider Relief Funds and similar programs in the U.K. and Canada, resulted in a benefit of approximately $21,204,000 for the three months ended March 31, 2021 as compared to an expense of $7,294,000 during the three months ended March 31, 2020. These costs included higher labor expenses, coupled with expenditures related to procurement of personal protective equipment and other supplies, net of any reimbursements.
In 2020 applications were made for amounts under Phase 2 and Phase 3 of the Provider Relief Fund related to our Seniors Housing Operating portfolio. During the first quarter, we received Provider Relief Funds of approximately $35,682,000, which was recognized as a reduction to COVID-19 costs within property operating expenses.
The fluctuations in depreciation and amortization are due to acquisitions, dispositions and transitions. To the extent that we acquire or dispose of additional properties in the future, these amounts will change accordingly. 
During the three months ended March 31, 2021 and 2020, we recorded impairment charges of $4,604,000 and $3,495,000, respectively, related to held for use properties in which the carrying values exceed the estimated fair value. Transaction costs related to asset acquisitions are capitalized as a component of the purchase price. Changes in the gain on sales of properties are related to the volume and timing of property sales and the sales prices. During the three months ended March 31, 2021, we recognized a gain on real estate disposition of $5,195,000 related to four properties. The fluctuation in other expenses is primarily due to the timing of noncapitalizable transaction costs associated with acquisitions and operator transitions. 
35

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
During the three months ended March 31, 2021, there were no Seniors Housing Operating construction projects completed. The following is a summary of our Seniors Housing Operating construction projects, excluding expansions, pending as of March 31, 2021 (dollars in thousands):                     
LocationUnitsCommitmentBalanceEst. Completion
Potomac, MD120$56,720 $55,657 2Q21
Beckenham, UK10064,97050,6604Q21
Barnet, UK10071,45345,1944Q21
Hendon, UK10276,55754,6984Q21
Georgetown, TX18836,2155,3084Q21
Princeton, NJ8029,78018,5593Q22
Berea, OH12014,9342,3444Q22
Painesville, OH11914,4621,8574Q22
Beaver, PA11614,1842,3904Q22
 1,045 $379,275 236,667  
Toronto, ONProject in planning stage47,970 
Brookline, MAProject in planning stage24,632 
Washington, DCProject in planning stage24,467 
Columbus, OHProject in planning stage11,634 
Brookhaven, GAProject in planning stage6,804 
Raleigh, NCProject in planning stage3,407 
$355,581 
Interest expense represents secured debt interest expense which fluctuates based on the net effect and timing of assumptions, segment transitions, fluctuations in foreign currency rates, extinguishments and principal amortizations. The fluctuations in loss (gain) on extinguishment of debt is primarily attributable to the volume of extinguishments and terms of the related secured debt. The following is a summary of our Seniors Housing Operating segment property secured debt principal activity (dollars in thousands):
 Three Months Ended
 March 31, 2021March 31, 2020
  Wtd. Avg. Wtd. Avg.
 AmountInterest RateAmountInterest Rate
Beginning balance$1,706,189 3.05 %$2,115,037 3.54 %
Debt issued— — %44,921 2.58 %
Debt extinguished(41,933)7.60 %(16,040)4.51 %
Principal payments(12,261)3.26 %(12,174)3.49 %
Foreign currency15,283 2.81 %(86,818)3.25 %
Ending balance$1,667,278 2.89 %$2,044,926 3.56 %
Monthly averages$1,688,213 2.99 %$2,080,448 3.54 %
The majority of our Seniors Housing Operating properties are formed through partnership interests. Income from unconsolidated entities recognized during the three months ended March 31, 2021 is primarily due to a gain on sale recognized from the sale of a home health business owned by one of our unconsolidated entities, offset by losses from unconsolidated entities largely attributable to depreciation and amortization of short-lived intangible assets related to certain investments in unconsolidated joint ventures. Net income attributable to noncontrolling interests represents our partners’ share of net income (loss) related to joint ventures.
Triple-net
The following is a summary of our SSNOI at Welltower's Share for the Triple-net segment (dollars in thousands):
QTD Pool
 Three Months EndedChange
 March 31, 2021March 31, 2020$%
SSNOI (1)
$141,089 $147,527 $(6,438)(4.4)%
(1) For the three months ended March 31, 2021 and 2020, amounts relate to 553 same store properties, respectively. Please see Non-GAAP Financial Measures for additional information and reconciliations.
36

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following is a summary of our results of operations for the Triple-net segment (dollars in thousands):
 Three Months EndedChange
 March 31,March 31,  
 20212020$%
Revenues:    
Rental income
$152,463 $191,385 $(38,922)(20)%
Interest income
14,922 14,671 251 %
Other income
1,097 1,673 (576)(34)%
Total revenues
168,482 207,729 (39,247)(19)%
Property operating expenses12,841 13,302 (461)(3)%
NOI (1)
155,641 194,427 (38,786)(20)%
Other expenses:    
Depreciation and amortization
56,667 57,694 (1,027)(2)%
Interest expense
1,882 2,852 (970)(34)%
Loss (gain) on derivatives and financial instruments, net
1,934 7,651 (5,717)(75)%
Provision for loan losses
853 7,072 (6,219)(88)%
Impairment of assets
18,964 24,332 (5,368)(22)%
Other expenses
4,983 513 4,470 871 %
85,283 100,114 (14,831)(15)%
Income (loss) from continuing operations before income taxes and other items70,358 94,313 (23,955)(25)%
Income (loss) from unconsolidated entities4,907 5,796 (889)(15)%
Gain (loss) on real estate dispositions, net2,042 49,637 (47,595)(96)%
Income from continuing operations77,307 149,746 (72,439)(48)%
Net income77,307 149,746 (72,439)(48)%
Less: Net income (loss) attributable to noncontrolling interests3,400 18,575 (15,175)(82)%
Net income attributable to common stockholders$73,907 $131,171 $(57,264)(44)%
(1) See Non-GAAP Financial Measures below.
Continued decreases in rental income are primarily attributable to the reserve for straight-line rent receivables balances of $49,241,000 and $32,268,000 during the three month periods ended March 31, 2021 and 2020, respectively, relating to leases for which collection of substantially all contractual lease payments was no longer deemed probable. Certain of our leases contain annual rental escalators that are contingent upon changes in the Consumer Price Index and/or changes in the gross operating revenues of the tenant’s properties. These escalators are not fixed, so no straight-line rent is recorded; however, rental income is recorded based on the contractual cash rental payments due for the period. If gross operating revenues at our facilities and/or the Consumer Price Index do not increase, a portion of our revenues may not continue to increase. For the three months ended March 31, 2021, we had 16 leases with rental rate increases ranging from 0.25% to 10.00% in our Triple-net portfolio. Our Triple-net operators are experiencing similar impacts on occupancy and operating costs due to the COVID-19 pandemic as described above with respect to our Seniors Housing Operating properties. However, long-term/post-acute facilities are generally experiencing a higher degree of occupancy declines which may impact the ability of our Triple-net operators to make contractual rent payments to us in the future. Many of our Triple-net operators received funds under the CARES Act Paycheck Protection Program. In addition, operators of long-term/post-acute facilities have generally received funds from Phase 1 of the Provider Relief Fund and operators of assisted living facilities have received funds from Phase 2 and Phase 3 of the Provider Relief Fund. During the first quarter, we collected approximately 96% of rent due from operators under Triple-net lease agreements (primarily seniors housing and post-acute care facilities). No significant rent deferrals or rent concessions have been made. We evaluate leases individually and recognize rent on a cash basis if collectibility of substantially all contractual rent payments is not probable.
Depreciation and amortization fluctuates as a result of the acquisitions, dispositions and transitions of triple-net properties. To the extent we acquire or dispose of additional properties in the future, our provision for depreciation and amortization will change accordingly. 
In March 2020, we recognized a provision for loan losses of $6,898,000 to fully reserve for a non-real estate loans receivable that was no longer deemed collectible. During the three months ended March 31, 2021, we recorded impairment charges of $18,964,000 related to one held for sale property and two held for use properties. During the three months ended March 31, 2020, we recorded impairment charges of $24,332,000 related to two held for use properties. Changes in the gain on sales of properties are related to the volume and timing of property sales and the sales prices. Transaction costs related to asset acquisitions are capitalized as a component of purchase price. The fluctuation in other expenses is primarily due to noncapitalizable transaction costs from acquisitions and segment transitions.
37

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
During the three months ended March 31, 2021, we completed one Triple-net construction project representing $22,990,000 or $280,366 per unit. The following is a summary of Triple-net construction projects, excluding expansions, pending as of March 31, 2021 (dollars in thousands): 
LocationUnits/BedsCommitmentBalanceEst. Completion
Redhill, UK76$21,932 $12,097 2Q21
Leicester, UK6015,4496,4951Q22
London, UK8244,50822,7382Q22
Wombourne, UK6616,5536,4342Q22
Rugby, UK7621,1233,7824Q22
Raleigh, NC191154,25620,1852Q23
 551 $273,821 $71,731  
Loss (gain) on derivatives and financial instruments, net is primarily attributable to the mark-to-market adjustment recorded on our Genesis Healthcare available-for-sale investment. Interest expense represents secured debt interest expense and related fees. The change in secured debt interest expense is due to the net effect and timing of assumptions, segment transitions, fluctuations in foreign currency rates, extinguishments and principal amortizations. The following is a summary of our Triple-net secured debt principal activity for the periods presented (dollars in thousands):
 Three Months Ended
 March 31, 2021March 31, 2020
  Wtd. Avg. Wtd. Avg.
 AmountInterest RateAmountInterest Rate
Beginning balance$123,652 4.91 %$306,038 3.60 %
Principal payments(1,220)5.15 %(1,059)5.17 %
Foreign currency707 5.43 %(15,240)3.40 %
Ending balance$123,139 4.91 %$289,739 3.55 %
Monthly averages$123,126 4.96 %$299,111 3.59 %
A portion of our Triple-net properties were formed through partnerships. Income or loss from unconsolidated entities represents our share of net income or losses from partnerships where we are the noncontrolling partner. Net income attributable to noncontrolling interests represents our partners’ share of net income relating to those partnerships where we are the controlling partner. The decrease during the three months ended March 31, 2021, relates primarily to our partner's share of a gain on sale of certain properties in the prior year.
Outpatient Medical
The following is a summary of our SSNOI at Welltower Share for the Outpatient Medical segment (dollars in thousands):
QTD Pool
 Three Months EndedChange
 March 31, 2021March 31, 2020$%
SSNOI (1)
$97,196 $94,208 $2,988 3.2 %
(1) For the three months ended March 31, 2021 and 2020, amounts relate to 334 same store properties, respectively. Please see Non-GAAP Financial Measures for additional information and reconciliations.
The following is a summary of our results of operations for the Outpatient Medical segment for the periods presented (dollars in thousands):
38

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
 Three Months EndedChange
 March 31,March 31,  
 20212020$%
Revenues:    
Rental income$150,380 $198,575 $(48,195)(24)%
Interest income3,538 466 3,072 659 %
Other income2,305 288 2,017 700 %
Total revenues156,223 199,329 (43,106)(22)%
Property operating expenses46,863 60,608 (13,745)(23)%
NOI (1)
109,360 138,721 (29,361)(21)%
Other expenses:    
Depreciation and amortization55,173 70,333 (15,160)(22)%
Interest expense4,015 4,808 (793)(16)%
Provision for loan losses279 — 279 n/a
Other expenses712 1,007 (295)(29)%
60,179 76,148 (15,969)(21)%
Income (loss) from continuing operations before income taxes and other items
49,181 62,573 (13,392)(21)%
Income (loss) from unconsolidated entities2,908 1,536 1,372 89 %
Gain (loss) on real estate dispositions, net51,843 213,336 (161,493)n/a
Income from continuing operations103,932 277,445 (173,513)(63)%
Net income (loss)103,932 277,445 (173,513)(63)%
Less: Net income (loss) attributable to noncontrolling interests2,170 2,453 (283)(12)%
Net income (loss) attributable to common stockholders$101,762 $274,992 $(173,230)(63)%
(1) See Non-GAAP Financial Measures.
Rental income has decreased for the three month period ending March 31, 2021 due primarily to significant dispositions that have closed subsequent to March 31, 2020. Certain of our leases contain annual rental escalators that are contingent upon changes in the Consumer Price Index. These escalators are not fixed, so no straight-line rent is recorded; however, rental income is recorded based on the contractual cash rental payments due for the period. If the Consumer Price Index does not increase, a portion of our revenues may not continue to increase. Our leases could renew above or below current rental rates, resulting in an increase or decrease in rental income. For the three months ended March 31, 2021, our consolidated outpatient medical portfolio signed 89,863 square feet of new leases and 541,434 square feet of renewals. The weighted-average term of these leases was six years, with a rate of $36.84 per square foot and tenant improvement and lease commission costs of $12.57 per square foot. Substantially all of these leases contain an annual fixed or contingent escalation rent structure ranging from 1.0% to 3.5%. 
We have collected 99% of rent due in the first quarter, with uncollected amounts primarily attributable to local jurisdictions with COVID-19 related ordinances providing temporary rent relief to tenants. We evaluate leases individually and recognize rent on a cash basis if collectibility of substantially all contractual rent payments is not probable.
The fluctuation in property operating expenses and depreciation and amortization are primarily attributable to the significant dispositions that occurred in 2020. To the extent that we acquire or dispose of additional properties in the future, these amounts will change accordingly. Changes in gains/losses on sales of properties are related to volume of property sales and the sales prices. Transaction costs related to asset acquisitions are capitalized as a component of purchase price. The fluctuation in other expenses is primarily due to noncapitalizable transaction costs from acquisitions and segment transitions.
During the three months ended March 31, 2021, there were no Outpatient Medical construction projects completed. The following is a summary of the Outpatient Medical construction projects, excluding expansions, pending as of March 31, 2021 (dollars in thousands):
LocationSquare FeetCommitmentBalanceEst. Completion
Brooklyn, NY140,955$110,306 $106,692 2Q21
Kalamazoo, MI40,60714,2675,9173Q21
College Station, TX25,2009,0251,1111Q22
206,762 $133,598 $113,720 
Total interest expense represents secured debt interest expense. The change in secured debt interest expense is primarily due to the net effect and timing of assumptions, extinguishments and principal amortizations. The following is a summary of our outpatient medical secured debt principal activity (dollars in thousands):
39

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
 Three Months Ended
 March 31, 2021March 31, 2020
  Wtd. Ave Wtd. Ave
 AmountInterest RateAmountInterest Rate
Beginning balance$548,229 3.55 %$572,267 3.97 %
Principal payments(2,474)4.46 %(2,293)4.65 %
Ending balance$545,755 3.54 %$569,974 3.94 %
Monthly averages$546,613 3.54 %$571,200 3.97 %
A portion of our Outpatient Medical properties were formed through partnerships. Income or loss from unconsolidated entities represents our share of net income or losses from partnerships where we are the noncontrolling partner. Net income attributable to noncontrolling interests represents our partners’ share of net income or loss relating to those partnerships where we are the controlling partner.
Non-Segment/Corporate
The following is a summary of our results of operations for the Non-Segment/Corporate activities for the periods presented (dollars in thousands):
 Three Months EndedChange
 March 31,March 31,  
 20212020$%
Revenues:    
Other income
$955 $416 $539 130 %
Total revenue
955 416 539 130 %
Property operating expenses1,654 — 1,654 n/a
NOI (1)
(699)416 (1,115)(268)%
Expenses:    
Interest expense
105,827 117,913 (12,086)(10)%
General and administrative expenses
29,926 35,481 (5,555)(16)%
Other expenses
1,840 1,783 57 %
137,593 155,177 (17,584)(11)%
Loss from continuing operations before income taxes and other items(138,292)(154,761)16,469 11 %
Income tax (expense) benefit(3,943)(5,442)1,499 28 %
Loss from continuing operations(142,235)(160,203)17,968 11 %
Net loss attributable to common stockholders$(142,235)$(160,203)$17,968 11 %
(1) See Non-GAAP Financial Measures.
Property operating expenses represent insurance costs related to our captive insurance company formed as of July 1, 2020 which acts as a direct insurer of property level insurance coverage for our portfolio.
The following is a summary of our Non-Segment/Corporate interest expense for the periods presented (dollars in thousands):
 Three Months EndedChange
 March 31,March 31,  
 20212020$%
Senior unsecured notes$100,213 $103,533 $(3,320)(3)%
Unsecured credit facility and commercial paper program1,180 10,169 (8,989)(88)%
Loan expense4,434 4,211 223 %
Totals$105,827 $117,913 $(12,086)(10)%
The change in interest expense on senior unsecured notes is due to the net effect of issuances and extinguishments, as well as the movement in foreign exchange rates and related hedge activity. Please refer to Note 11 for additional information. The change in interest expense on our unsecured revolving credit facility and commercial paper program is due primarily to the net effect and timing of draws, paydowns and variable interest rate changes. Please refer to Note 10 for additional information regarding our unsecured revolving credit facility and commercial paper program.
40

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
General and administrative expenses as a percentage of consolidated revenues for the three months ended March 31, 2021 and 2020 were 2.84% and 2.82%, respectively. The provision for income taxes primarily relates to state taxes, foreign taxes and taxes based on income generated by entities that are structured as TRSs.
Other
Non-GAAP Financial Measures
We believe that net income and net income attributable to common stockholders (“NICS”), as defined by U.S. GAAP, are the most appropriate earnings measurements. However, we consider FFO, NOI, SSNOI, EBITDA and Adjusted EBITDA to be useful supplemental measures of our operating performance. Historical cost accounting for real estate assets in accordance with U.S. GAAP implicitly assumes that the value of real estate assets diminishes predictably over time as evidenced by the provision for depreciation. However, since real estate values have historically risen or fallen with market conditions, many industry investors and analysts have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient. In response, the National Association of Real Estate Investment Trusts (“NAREIT”) created funds from operations attributable to common stockholders (“FFO”) as a supplemental measure of operating performance for REITs that excludes historical cost depreciation from net income. FFO, as defined by NAREIT, means NICS, computed in accordance with U.S. GAAP, excluding gains (or losses) from sales of real estate and impairment of depreciable assets, plus depreciation and amortization, and after adjustments for unconsolidated entities and noncontrolling interests.
Consolidated net operating income (“NOI”) is used to evaluate the operating performance of our properties. We define NOI as total revenues, including tenant reimbursements, less property operating expenses. Property operating expenses represent costs associated with managing, maintaining and servicing tenants for our properties. These expenses include, but are not limited to, property-related payroll and benefits, property management fees paid to operators, marketing, housekeeping, food service, maintenance, utilities, property taxes and insurance. General and administrative expenses represent costs unrelated to property operations. These expenses include, but are not limited to, payroll and benefits, professional services, office expenses and depreciation of corporate fixed assets. Same store NOI (“SSNOI”) is used to evaluate the operating performance of our properties using a consistent population which controls for changes in the composition of our portfolio. We believe the drivers of property level NOI for both consolidated properties and unconsolidated properties are generally the same and therefore, we evaluate SSNOI based on our ownership interest in each property ("Welltower Share"). To arrive at Welltower's Share, NOI is adjusted by adding our minority ownership share related to unconsolidated properties and by subtracting the minority partners' noncontrolling ownership interests for consolidated properties. We do not control investments in unconsolidated properties and while we consider disclosures at Welltower Share to be useful, they may not accurately depict the legal and economic implications of our joint venture arrangements and should be used with caution. As used herein, same store is generally defined as those revenue-generating properties in the portfolio for the relevant year-over-year reporting periods. Acquisitions and development conversions are included in SSNOI five full quarters after acquisition or being placed into service for the QTD Pool. Land parcels, loans and sub-leases, as well as any properties sold or classified as held for sale during the respective periods are excluded from SSNOI. Redeveloped properties (including major refurbishments of a Seniors Housing Operating property where 20% or more of units are simultaneously taken out of commission for 30 days or more or Outpatient Medical properties undergoing a change in intended use) are excluded from SSNOI until five full quarters post completion of the redevelopment for the QTD Pool. Properties undergoing operator transitions and/or segment transitions are also excluded from SSNOI until five full quarters post completion of the transition for the QTD Pool. In addition, properties significantly impacted by force majeure, acts of God, or other extraordinary adverse events are excluded from SSNOI until five full quarters after the properties are placed back into service for the QTD Pool. SSNOI excludes non-cash NOI and includes adjustments to present consistent ownership percentages and to translate Canadian properties and UK properties using a consistent exchange rate. We believe NOI and SSNOI provide investors relevant and useful information because they measure the operating performance of our properties at the property level on an unleveraged basis. We use NOI and SSNOI to make decisions about resource allocations and to assess the property level performance of our properties.
EBITDA is defined as earnings (net income) before interest, taxes, depreciation and amortization. Adjusted EBITDA is defined as EBITDA excluding unconsolidated entities and including adjustments for stock-based compensation expense, provision for loan losses, gains/losses on extinguishment of debt, gains/loss/impairments on properties, gains/losses on derivatives and financial instruments, other expense, additional other income and other impairment charges. We believe that EBITDA and Adjusted EBITDA, along with net income, are important supplemental measures because they provide additional information to assess and evaluate the performance of our operations. We primarily use these measures to determine our interest coverage ratio, which represents EBITDA and Adjusted EBITDA divided by total interest, and our fixed charge coverage ratio, which represents EBITDA and Adjusted EBITDA divided by fixed charges. Fixed charges include total interest and secured debt principal amortization. Covenants in our unsecured senior notes and primary credit facility contain financial ratios based on a definition of EBITDA and Adjusted EBITDA that is specific to those agreements. Our leverage ratios are defined as the proportion of net debt to total capitalization and include book capitalization, undepreciated book capitalization and market capitalization. Book capitalization represents the sum of net debt (defined as total long-term debt, excluding operating lease
41

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
liabilities, less cash and cash equivalents and any IRC Section 1031 deposits), total equity and redeemable noncontrolling interests. Undepreciated book capitalization represents book capitalization adjusted for accumulated depreciation and amortization. Market capitalization represents book capitalization adjusted for the fair market value of our common stock.
Our supplemental reporting measures and similarly entitled financial measures are widely used by investors, equity and debt analysts and rating agencies in the valuation, comparison, rating and investment recommendations of companies. Management uses these financial measures to facilitate internal and external comparisons to our historical operating results and in making operating decisions. Additionally, these measures are utilized by the Board of Directors to evaluate management. None of our supplemental measures represent net income or cash flow provided from operating activities as determined in accordance with U.S. GAAP and should not be considered as alternative measures of profitability or liquidity. Finally, the supplemental measures, as defined by us, may not be comparable to similarly entitled items reported by other real estate investment trusts or other companies. 
The table below reflects the reconciliation of FFO to NICS, the most directly comparable U.S. GAAP measure, for the periods presented. Noncontrolling interest and unconsolidated entity amounts represent adjustments to reflect our share of depreciation and amortization, gains/loss on real estate dispositions and impairment of assets. Amounts are in thousands except for per share data.
 
 March 31,December 31,September 30,June 30,March 31,
FFO Reconciliation:20212020202020202020
Net income attributable to common stockholders$71,546 $163,729 $325,585 $179,246 $310,284 
Depreciation and amortization244,426 242,733 255,532 265,371 274,801 
Impairment of assets23,568 9,317 23,313 75,151 27,827 
Loss (gain) on real estate dispositions, net(59,080)(185,464)(484,304)(155,863)(262,824)
Noncontrolling interests(12,516)(20,579)48,559 (42,539)(9,409)
Unconsolidated entities19,223 16,091 16,329 14,231 15,445 
FFO$287,167 $225,827 $185,014 $335,597 $356,124 
Average diluted shares outstanding419,079 418,753 418,987 419,121 412,420 
Per diluted share data:   
Net income attributable to common stockholders(1)
$0.17 $0.39 $0.77 $0.42 $0.75 
FFO$0.69 $0.54 $0.44 $0.80 $0.86 
(1) Includes adjustment to the numerator for income (loss) attributable to OP unitholders.
42

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
 Three Months Ended
 March 31,December 31,September 30,June 30,March 31,
NOI Reconciliations:20212020202020202020
Net income (loss)$72,192 $155,278 $394,978 $159,216 $329,380 
Loss (gain) on real estate dispositions, net(59,080)(185,464)(484,304)(155,863)(262,824)
Loss (income) from unconsolidated entities(13,049)(258)5,981 (1,332)3,692 
Income tax expense (benefit)3,943 290 2,003 2,233 5,442 
Other expenses10,994 33,088 11,544 19,411 6,292 
Impairment of assets23,568 9,317 23,313 75,151 27,827 
Provision for loan losses1,383 83,085 2,857 1,422 7,072 
Loss (gain) on extinguishment of debt, net(4,643)13,796 33,004 249 — 
Loss (gain) on derivatives and financial instruments, net1,934 569 1,395 1,434 7,651 
General and administrative expenses29,926 27,848 31,003 34,062 35,481 
Depreciation and amortization244,426 242,733 255,532 265,371 274,801 
Interest expense123,142 121,173 124,851 126,357 142,007 
Consolidated net operating income (NOI)$434,736 $501,455 $402,157 $527,711 $576,821 
NOI by segment:   
Seniors Housing Operating$170,434 $159,797 $174,361 $178,137 $243,257 
Triple-net155,641 225,277 108,361 220,056 194,427 
Outpatient Medical109,360 117,231 119,976 129,143 138,721 
Non-segment/corporate(699)(850)(541)375 416 
Total NOI$434,736 $501,455 $402,157 $527,711 $576,821 

QTD Pool
SSNOI Property Reconciliations:Seniors Housing OperatingTriple-netOutpatient MedicalTotal
Consolidated properties
559 649 290 1,498 
Unconsolidated properties
90 39 79 208 
Total properties
649 688 369 1,706 
Recent acquisitions/development conversions(1)
(34)(26)(21)(81)
Under development
(28)(5)(3)(36)
Under redevelopment(2)
(11)(1)(2)(14)
Current held for sale
(9)(61)(1)(71)
Land parcels, loans and subleases
(12)(17)(8)(37)
Transitions(3)
(27)(23)— (50)
Other(4)
(2)(2)— (4)
Same store properties
526 553 334 1,413 
(1) Acquisitions and development conversions will enter the QTD Pool five full quarters after acquisition or certificate of occupancy, respectively.
(2) Redevelopment properties will enter the QTD Pool five full quarters of operations post redevelopment completion, respectively.
(3) Transitioned properties will enter the QTD Pool five full quarters of operations with the new operator in place or under the new structure, respectively.
(4) Represents properties that are either closed or being closed.
43

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
QTD Pool
Three Months Ended
SSNOI Reconciliations:March 31, 2021March 31, 2020
Seniors Housing Operating:
 
Consolidated NOI
$170,434 $243,257 
NOI attributable to unconsolidated investments
11,904 14,954 
NOI attributable to noncontrolling interests
(10,278)(18,754)
NOI attributable to non-same store properties
(14,428)(22,515)
Non-cash NOI attributable to same store properties
(822)(879)
Currency and ownership adjustments (1)
(19)3,693 
SSNOI at Welltower Share156,791 219,756 
Triple-net:
Consolidated NOI
155,641 194,427 
NOI attributable to unconsolidated investments
4,888 5,133 
NOI attributable to noncontrolling interests
(8,037)(14,783)
NOI attributable to non-same store properties
(48,126)(26,394)
Non-cash NOI attributable to same store properties
36,711 (12,257)
Currency and ownership adjustments (1)
12 1,401 
SSNOI at Welltower Share141,089 147,527 
Outpatient Medical:
Consolidated NOI
109,360 138,721 
NOI attributable to unconsolidated investments
4,724 1,063 
NOI attributable to noncontrolling interests
(4,686)(4,358)
NOI attributable to non-same store properties
(8,604)(20,235)
Non-cash NOI attributable to same store properties
(2,447)(3,762)
Currency and ownership adjustments (1)
(1,151)(17,221)
SSNOI at Welltower Share97,196 94,208 
SSNOI at Welltower Share:
Seniors Housing Operating156,791 219,756 
Triple-net141,089 147,527 
Outpatient Medical97,196 94,208 
Total$395,076 $461,491 
(1) Includes adjustments to reflect consistent property ownership percentages, to translate Canadian properties at a USD/CAD rate of 1.2658 and to translate UK properties at a GBP/USD rate of 1.38.














44

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The tables below reflects the reconciliation of EBITDA to net income, the most directly comparable U.S. GAAP measure, for the periods presented. Dollars are in thousands.
 Three Months Ended
 March 31,December 31,September 30,June 30,March 31,
EBITDA Reconciliations:20212020202020202020
Net income (loss)$72,192 $155,278 $394,978 $159,216 $329,380 
Interest expense123,142 121,173 124,851 126,357 142,007 
Income tax expense (benefit)3,943 290 2,003 2,233 5,442 
Depreciation and amortization244,426 242,733 255,532 265,371 274,801 
EBITDA$443,703 $519,474 $777,364 $553,177 $751,630 
Interest Coverage Ratio:   
Interest expense$123,142 $121,173 $124,851 $126,357 $142,007 
Non-cash interest expense(2,991)(1,739)(3,973)(1,914)(8,125)
Capitalized interest4,496 4,238 3,947 4,541 4,746 
Total interest
124,647 123,672 124,825 128,984 138,628 
EBITDA$443,703 $519,474 $777,364 $553,177 $751,630 
Interest coverage ratio
3.56 x4.20 x6.23 x4.29 x5.42 x
Fixed Charge Coverage Ratio:   
Total interest$124,647 $123,672 $124,825 $128,984 $138,628 
Secured debt principal payments15,955 16,122 15,876 15,183 15,526 
Total fixed charges
140,602 139,794 140,701 144,167 154,154 
EBITDA$443,703 $519,474 $777,364 $553,177 $751,630 
Fixed charge coverage ratio
3.16 x3.72 x5.52 x3.84 x4.88 x

45

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The table below reflects the reconciliation of Adjusted EBITDA to net income, the most directly comparable U.S. GAAP measure, for the periods presented. Dollars are in thousands.
 Twelve Months Ended
March 31,December 31,September 30,June 30,March 31,
Adjusted EBITDA Reconciliations:20212020202020202020
Net income$781,664 $1,038,852 $1,123,710 $1,376,664 $1,367,488 
Interest expense495,523 514,388 524,863 537,355 552,334 
Income tax expense (benefit)8,469 9,968 4,846 6,811 6,177 
Depreciation and amortization1,008,062 1,038,437 1,058,348 1,075,261 1,057,942 
EBITDA
2,293,718 2,601,645 2,711,767 2,996,091 2,983,941 
Loss (income) from unconsolidated entities(8,658)8,083 (49,079)(58,322)(47,941)
Stock-based compensation expense (1)
26,811 28,318 25,485 24,229 24,601 
Loss (gain) on extinguishment of debt, net42,406 47,049 35,865 68,685 68,436 
Loss (gain) on real estate dispositions, net(884,711)(1,088,455)(915,055)(1,001,001)(843,456)
Impairment of assets131,349 135,608 126,389 121,172 55,960 
Provision for loan losses88,747 94,436 11,351 8,494 7,072 
Loss (gain) on derivatives and financial instruments, net5,332 11,049 5,411 5,260 5,739 
Other expenses (1)
68,939 64,171 52,630 46,971 48,327 
Other impairment (2)
163,481 146,508 146,508 34,110 32,268 
Adjusted EBITDA$1,927,414 $2,048,412 $2,151,272 $2,245,689 $2,334,947 
Adjusted Interest Coverage Ratio:   
Interest expense$495,523 $514,388 $524,863 $537,355 $552,334 
Capitalized interest17,222 17,472 18,102 18,303 17,691 
Non-cash interest expense(10,617)(15,751)(14,746)(12,761)(11,599)
Total interest
502,128 516,109 528,219 542,897 558,426 
Adjusted EBITDA$1,927,414 $2,048,412 $2,151,272 $2,245,689 $2,334,947 
Adjusted interest coverage ratio
3.84 x3.97 x4.07 x4.14 x4.18 x
Adjusted Fixed Charge Coverage Ratio:
Total interest$502,128 $516,109 $528,219 $542,897 $558,426 
Secured debt principal payments63,136 62,707 60,562 57,807 56,308 
Total fixed charges
565,264 578,816 588,781 600,704 614,734 
Adjusted EBITDA$1,927,414 $2,048,412 $2,151,272 $2,245,689 $2,334,947 
Adjusted fixed charge coverage ratio
3.41 x3.54 x3.65 x3.74 x3.80 x
(1) Certain severance-related costs are included in stock-based compensation and excluded from other expenses.
(2) Represents reserve for straight-line rent receivable balances relating to leases placed on cash recognition.

Our leverage ratios include book capitalization, undepreciated book capitalization and market capitalization. Book capitalization represents the sum of net debt (defined as total long-term debt less cash and cash equivalents and any IRC Section 1031 deposits), total equity and redeemable noncontrolling interests. Undepreciated book capitalization represents book capitalization adjusted for accumulated depreciation and amortization. Market capitalization represents book capitalization adjusted for the fair market value of our common stock. Our leverage ratios are defined as the proportion of net debt to total capitalization. The table below reflects the reconciliation of our leverage ratios to our balance sheets for the periods presented. Amounts are in thousands, except share price. 
46

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
As of
 March 31,December 31,September 30,June 30,March 31,
 20212020202020202020
Book capitalization:   
Unsecured credit facility and commercial paper$— $— $— $— $844,985 
Long-term debt obligations (1)
14,618,713 13,905,822 13,889,030 14,543,485 13,228,433 
Cash and cash equivalents (2)
(2,513,156)(1,968,765)(2,096,571)(1,766,819)(303,423)
Total net debt12,105,557 11,937,057 11,792,459 12,776,666 13,769,995 
Total equity and noncontrolling interests(3)
17,046,932 17,225,062 17,291,155 17,263,672 17,495,696 
Book capitalization$29,152,489 $29,162,119 $29,083,614 $30,040,338 $31,265,691 
Net debt to book capitalization ratio
42 %41 %41 %43 %44 %
Undepreciated book capitalization:   
Total net debt$12,105,557 $11,937,057 $11,792,459 $12,776,666 $13,769,995 
Accumulated depreciation and amortization6,212,432 6,104,297 6,002,775 6,001,177 5,910,979 
Total equity and noncontrolling interests(3)
17,046,932 17,225,062 17,291,155 17,263,672 17,495,696 
Undepreciated book capitalization$35,364,921 $35,266,416 $35,086,389 $36,041,515 $37,176,670 
Net debt to undepreciated book capitalization ratio34 %34 %34 %35 %37 %
Market capitalization:   
Common shares outstanding417,520 417,401 417,305 417,302 417,391 
Period end share price$71.63 $64.62 $55.09 $51.75 $45.78 
Common equity market capitalization$29,906,958 $26,972,453 $22,989,332 $21,595,379 $19,108,160 
Total net debt12,105,557 11,937,057 11,792,459 12,776,666 13,769,995 
Noncontrolling interests(3)
1,248,054 1,252,343 1,183,281 1,215,532 1,362,913 
Market capitalization$43,260,569 $40,161,853 $35,965,072 $35,587,577 $34,241,068 
Net debt to market capitalization ratio
28 %30 %33 %36 %40 %
(1) Amounts include senior unsecured notes, secured debt and lease liabilities related to financing leases, as reflected on our Consolidated Balance Sheets. Operating lease liabilities related to the ASC 842 adoption are excluded.
(2) Inclusive of IRC Section 1031 deposits, if any.
(3) Includes amounts attributable to both redeemable noncontrolling interests and noncontrolling interests as reflected on our Consolidated Balance Sheets.

Critical Accounting Policies
Our unaudited consolidated financial statements are prepared in accordance with U.S. GAAP, which requires us to make estimates and assumptions. Management considers an accounting estimate or assumption critical if:
the nature of the estimates or assumptions is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change; and
the impact of the estimates and assumptions on financial condition or operating performance is material.
Management has discussed the development and selection of its critical accounting policies with the Audit Committee of the Board of Directors. Management believes the current assumptions and other considerations used to estimate amounts reflected in our unaudited consolidated financial statements are appropriate and are not reasonably likely to change in the future. However, since these estimates require assumptions to be made that were uncertain at the time the estimate was made, they bear the risk of change. If actual experience differs from the assumptions and other considerations used in estimating amounts reflected in our unaudited consolidated financial statements, the resulting changes could have a material adverse effect on our consolidated results of operations, liquidity and/or financial condition. Please refer to Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2020 for further information regarding significant accounting policies that impact us. There have been no material changes to these policies in 2021.
47

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Cautionary Statement Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q may contain “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. When Welltower uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “pro forma,” “estimate” or similar expressions that do not relate solely to historical matters, Welltower is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause Welltower’s actual results to differ materially from Welltower’s expectations discussed in the forward-looking statements. This may be a result of various factors, including, but not limited to: the duration and scope of the COVID-19 pandemic; uncertainty regarding the implementation and impact of the CARES Act and future stimulus or other COVID-19 relief legislation; the impact of the COVID-19 pandemic on occupancy rates and on the operations of Welltower and its operators/tenants; actions governments take in response to the COVID-19 pandemic, including the introduction of public health measures and other regulations affecting Welltower’s properties and the operations of Welltower and its operators/tenants; the effects of health and safety measures adopted by Welltower and its operators/tenants related to the COVID-19 pandemic; increased operational costs as a result of health and safety measures related to COVID-19; the impact of the COVID-19 pandemic on the business and financial condition of operators/tenants and their ability to make payments to Welltower; disruptions to Welltower's property acquisition and disposition activity due to economic uncertainty caused by COVID-19; general economic uncertainty in key markets as a result of the COVID-19 pandemic and a worsening of global economic conditions or low levels of economic growth; the status of capital markets, including availability and cost of capital; uncertainty from the expected discontinuance of LIBOR and the transition to any other interest rate benchmark; issues facing the health care industry, including compliance with, and changes to, regulations and payment policies, responding to government investigations and punitive settlements and operators’/tenants’ difficulty in cost effectively obtaining and maintaining adequate liability and other insurance; changes in financing terms; competition within the health care and seniors housing industries; negative developments in the operating results or financial condition of operators/tenants, including, but not limited to, their ability to pay rent and repay loans; Welltower’s ability to transition or sell properties with profitable results; the failure to make new investments or acquisitions as and when anticipated; natural disasters and other acts of God affecting Welltower’s properties; Welltower’s ability to re-lease space at similar rates as vacancies occur; Welltower’s ability to timely reinvest sale proceeds at similar rates to assets sold; operator/tenant or joint venture partner bankruptcies or insolvencies; the cooperation of joint venture partners; government regulations affecting Medicare and Medicaid reimbursement rates and operational requirements; liability or contract claims by or against operators/tenants; unanticipated difficulties and/or expenditures relating to future investments or acquisitions; environmental laws affecting Welltower’s properties; changes in rules or practices governing Welltower’s financial reporting; the movement of U.S. and foreign currency exchange rates; Welltower’s ability to maintain Welltower’s qualification as a REIT; key management personnel recruitment and retention; and other risks described in Welltower’s reports filed from time to time with the SEC. Other important factors are identified in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, including factors identified under the headings “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Finally, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, or to update the reasons why actual results could differ from those projected in any forward-looking statements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates and foreign currency exchange rates. We seek to mitigate the underlying foreign currency exposures with gains and losses on derivative contracts hedging these exposures. We seek to mitigate the effects of fluctuations in interest rates by matching the terms of new investments with new long-term fixed rate borrowings to the extent possible. We may or may not elect to use financial derivative instruments to hedge interest rate exposure. These decisions are principally based on our policy to match our variable rate investments with comparable borrowings, but are also based on the general trend in interest rates at the applicable dates and our perception of the future volatility of interest rates. This section is presented to provide a discussion of the risks associated with potential fluctuations in interest rates and foreign currency exchange rates.
We historically borrow on our unsecured revolving credit facility and commercial paper program to acquire, construct or make loans relating to health care and seniors housing properties. Then, as market conditions dictate, we will issue equity or long-term fixed rate debt to repay the borrowings under our unsecured revolving credit facility and commercial paper program. We are subject to risks associated with debt financing, including the risk that existing indebtedness may not be refinanced or that the terms of refinancing may not be as favorable as the terms of current indebtedness. The majority of our borrowings were completed under indentures or contractual agreements that limit the amount of indebtedness we may incur. Accordingly, in the event that we are unable to raise additional equity or borrow money because of these limitations, our ability to acquire additional properties may be limited.

48

Item 3. Quantitative and Qualitative Disclosures About Market Risk
A change in interest rates will not affect the interest expense associated with our fixed rate debt. Interest rate changes, however, will affect the fair value of our fixed rate debt. Changes in the interest rate environment upon maturity of this fixed rate debt could have an effect on our future cash flows and earnings, depending on whether the debt is replaced with other fixed rate debt, variable rate debt or equity or repaid by the sale of assets. To illustrate the impact of changes in the interest rate markets, we performed a sensitivity analysis on our fixed rate debt instruments whereby we modeled the change in net present values arising from a hypothetical 1% increase in interest rates to determine the instruments’ change in fair value. The following table summarizes the analysis performed as of the dates indicated (in thousands):
 March 31, 2021December 31, 2020
 PrincipalChange inPrincipalChange in
 balancefair valuebalancefair value
Senior unsecured notes$10,710,742 $(760,313)$9,943,501 $(761,581)
Secured debt1,600,119 (53,176)1,702,196 (57,756)
Totals$12,310,861 $(813,489)$11,645,697 $(819,337)
Our variable rate debt, including our unsecured revolving credit facility and commercial paper program, is reflected at fair value. At March 31, 2021, we had $2,304,903,000 outstanding related to our variable rate debt. Assuming no changes in outstanding balances, a 1% increase in interest rates would result in increased annual interest expense of $23,050,000. At December 31, 2020, we had $2,241,909,000 outstanding under our variable rate debt. Assuming no changes in outstanding balances, a 1% increase in interest rates would have resulted in increased annual interest expense of $22,420,000. 
We are subject to currency fluctuations that may, from time to time, affect our financial condition and results of operations. Increases or decreases in the value of the Canadian Dollar or British Pounds Sterling relative to the U.S. Dollar impact the amount of net income we earn from our investments in Canada and the United Kingdom. Based solely on our results for the three months ended March 31, 2021, including the impact of existing hedging arrangements, if these exchange rates were to increase or decrease by 10%, our net income from these investments would increase or decrease, as applicable, by less than $2,000,000. We will continue to mitigate these underlying foreign currency exposures with non-U.S. denominated borrowings and gains and losses on derivative contracts. If we increase our international presence through investments in, or acquisitions or development of, seniors housing and health care properties outside the U.S., we may also decide to transact additional business or borrow funds in currencies other than U.S. Dollars, Canadian Dollars or British Pounds Sterling. To illustrate the impact of changes in foreign currency markets, we performed a sensitivity analysis on our derivative portfolio whereby we modeled the change in net present values arising from a hypothetical 1% increase in foreign currency exchange rates to determine the instruments’ change in fair value. The following table summarizes the results of the analysis performed (dollars in thousands):
 March 31, 2021December 31, 2020
 CarryingChange inCarryingChange in
 Valuefair valueValuefair value
Foreign currency exchange contracts$84,219 $12,367 $61,851 $12,731 
Debt designated as hedges1,647,220 16,472 1,630,542 16,305 
Totals$1,731,439 $28,839 $1,692,393 $29,036 
For additional information regarding fair values of financial instruments, see “Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies” and Notes 12 and 17 to our unaudited consolidated financial statements.
Item 4. Controls and Procedures
Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective in providing reasonable assurance that information required to be disclosed by us in the reports we file with or submit to the SEC under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. No changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) occurred during the fiscal quarter covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
49


PART II. OTHER INFORMATION
Item 1. Legal Proceedings
From time to time, there are various legal proceedings pending against us that arise in the ordinary course of our business. Management does not believe that the resolution of any of these legal proceedings either individually or in the aggregate will have a material adverse effect on our business, results of operations or financial condition. Further, from time to time, we are party to certain legal proceedings for which third parties, such as tenants, operators and/or managers are contractually obligated to indemnify, defend and hold us harmless. In some of these matters, the indemnitors have insurance for the potential damages. In other matters, we are being defended by tenants and other obligated third parties and these indemnitors may not have sufficient insurance, assets, income or resources to satisfy their defense and indemnification obligations to us. The unfavorable resolution of such legal proceedings could, individually or in the aggregate, materially adversely affect the indemnitors’ ability to satisfy their respective obligations to us, which, in turn, could have a material adverse effect on our business, results of operations or financial condition. It is management’s opinion that there are currently no such legal proceedings pending that will, individually or in the aggregate, have such a material adverse effect. Despite management’s view of the ultimate resolution of these legal proceedings, we may have significant legal expenses and costs associated with the defense of such matters. Further, management cannot predict the outcome of these legal proceedings and if management’s expectation regarding such matters is not correct, such proceedings could have a material adverse effect on our business, results of operations or financial condition.
Item 1A. Risk Factors
There have been no material changes from the risk factors identified under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2020.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
During the three months ended March 31, 2021, we acquired shares of our common stock held by employees who tendered shares to satisfy tax withholding obligations upon the vesting of previously issued restricted stock awards. Specifically, the number of shares of common stock acquired from employees and the average prices paid per share for each month in the first quarter ended March 31, 2021 are as shown in the table below.
On May 1, 2020, our Board of Directors authorized a share repurchase program whereby we may repurchase up to $1 billion of common stock through December 31, 2021 (the "Repurchase Program"). Under this authorization, we are not required to purchase shares but may choose to do so in the open market or through private transactions at times and amounts based on our evaluation of market conditions and other factors. We expect to finance any share repurchases under the Repurchase Program using available cash and may use proceeds from borrowings or debt offerings. We did not repurchase any shares of our common stock during the three months ended March 31, 2021.
Issuer Purchases of Equity Securities
PeriodTotal Number of Shares PurchasedAverage Price Paid Per ShareTotal Number of Shares Purchased as Part of Publicly Announced Repurchase ProgramMaximum Dollar Value of Shares that May Yet Be Purchased Under the Repurchase Program
January 1, 2021 through January 31, 202129,778 $64.31 — $— 
February 1, 2021 through February 28, 202124,080 67.30 — — 
March 1, 2021 through March 31, 20218,308 66.32 — — 
Totals62,166 $65.74 — $992,348,000 
Item 5. Other Information 
None.

50


Item 6. Exhibits
4.1
31.1
31.2
32.1
32.2
101.INSXBRL Instance Document. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHXBRL Taxonomy Extension Schema Document
101.CALXBRL Taxonomy Extension Calculation Linkbase Document
101.LABXBRL Taxonomy Extension Label Linkbase Document
101.PREXBRL Taxonomy Extension Presentation Linkbase Document
101.DEFXBRL Taxonomy Extension Definition Linkbase Document
104The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2021, formatted in Inline XBRL
*Management contract or Compensatory Plan or Arrangement.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
WELLTOWER INC.
  
 
Date:April 29, 2021By:  /s/ SHANKH MITRA 
 Shankh Mitra,  
 Chief Executive Officer and Chief Investment Officer
 (Principal Executive Officer) 
 
 
   
Date:April 29, 2021By:  /s/ TIMOTHY G. MCHUGH   
 Timothy G. McHugh,  
 Executive Vice President and Chief Financial Officer
 (Principal Financial Officer) 
 
 
   
Date:April 29, 2021By:  /s/ JOSHUA T. FIEWEGER  
 Joshua T. Fieweger,  
 Chief Accounting Officer
 (Principal Accounting Officer) 
 
51